Disorders of refraction and accommodation

H7_REFRAACCOMMODIS

obsolete_refractive error: ['Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.']

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H52 Cause of death: ICD-10 — H52 2 out of 7 registries used, show all original rules.	12275
4. Check minimum number of events None	12275
5. Include endpoints H7_HYPERMETRO H7_MYOPIA H7_ASTIGMATISM H7_ANISOMETROPIA H7_PRESBYOPIA H7_ACCOMMODIS H7_REFRADISNAS	12727
6. Filter based on genotype QC (FinnGen only)	12727

Control definitions (FinnGen only)

Control exclude: H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H49-H52
Name in latin: Perturbationes refractionis et accommodationis (oculi)

NAME	H7_REFRAACCOMMODIS
CONTROL_EXCLUDE	H7_OCUMUSCLE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_HYPERMETRO\|H7_MYOPIA\|H7_ASTIGMATISM\|H7_ANISOMETROPIA\|H7_PRESBYOPIA\|H7_ACCOMMODIS\|H7_REFRADISNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H52
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H52
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of refraction and accommodation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	129024	71773	56859
Only index persons	107279	60800	46479
Unadjusted period prevalence (%)
Whole population	1.84	2.06	1.59
Only index persons	2.04	2.24	1.77
Median age at first event (years)
Whole population	16.51	19.23	12.93
Only index persons	25.00	29.26	19.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12727	8381	4346
Unadjusted period prevalence (%)	2.54	2.86	1.92
Median age at first event (years)	46.86	44.93	50.58

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11023: Matched controls
109830

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CGD20

NOMESCO Finland

Laser-assisted in situ keratomileusis

1808.7

323.0

499

H52.2

ICD-10 Finland

Astigmatism

172.1

323.0

2066

147

H52.1

ICD-10 Finland

Myopia

148.3

323.0

4808

570

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

176.8

323.0

882

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.4

323.0

4574

24916

H52.0

ICD-10 Finland

Hypermetropia

174.5

323.0

2336

169

CGD10

NOMESCO Finland

Laser keratoplasty for error of refraction

112.9

323.0

383

H52.4

ICD-10 Finland

Presbyopia

43.2

323.0

1930

537

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.9

323.0

1591

4525

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.7

311.7

2502

10613

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.3

288.1

3530

18675

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.8

279.1

1335

3890

H53.0

ICD-10 Finland

Amblyopia ex anopsia

24.9

273.3

393

163

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.6

251.5

2135

9210

H50.0

ICD-10 Finland

Convergent concomitant strabismus

418.7

247.7

248

H52.5

ICD-10 Finland

Disorders of accommodation

334.2

229.6

232

XCK00

NOMESCO Finland

Perimetry

4.1

215.6

913

2366

H50.31

ICD-10 Finland

Intermittent exotropia

354.3

209.3

211

H50.52

ICD-10 Finland

Exophoria

52.6

209.3

253

H50.30

ICD-10 Finland

Intermittent esotropy

189.9

162.0

169

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

1626.9

160.5

156

H50.1

ICD-10 Finland

Divergent concomitant strabismus

324.6

160.1

162

37002

ICD-8 Finland

Refractive errors, Myopia

+∞

148.0

142

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.9

140.5

953

3501

H25.1

ICD-10 Finland

Senile nuclear cataract

2.1

126.5

1653

8519

H53.1

ICD-10 Finland

Subjective visual disturbances

3.0

125.3

789

2754

H53.2

ICD-10 Finland

Diplopia

5.5

124.8

391

734

ZXA10

NOMESCO Finland

Bilateral

2.0

124.2

1885

10313

H25.0

ICD-10 Finland

Senile incipient cataract

3.6

121.0

592

1716

H26.4

ICD-10 Finland

After-cataract

3.0

118.7

754

2645

H40.0

ICD-10 Finland

Glaucoma suspect

2.9

118.2

782

2817

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

117.5

1102

4856

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

+∞

114.6

110

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.1

113.2

672

2249

37300

ICD-8 Finland

Strabismus, Concomitans convergens

+∞

110.4

106

37301

ICD-8 Finland

Strabismus, Concomitans divergens

+∞

104.2

100

FEMTO

NOMESCO Finland

983.8

100.1

H50.2

ICD-10 Finland

Vertical strabismus

86.8

100.0

112

H50.51

ICD-10 Finland

Esophoria

61.5

88.7

104

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

87.5

923

4279

3671A

ICD-9 Finland

Disorders of refraction and accommodation, Myopia

+∞

87.5

H26.02

ICD-10 Finland

Presenil cataract

4.2

85.5

339

816

CG2T4

NOMESCO Finland

Topography assessment of cornea

9.0

84.6

184

206

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

79.0

857

4018

37000

ICD-8 Finland

Refractive errors, Astigmatismus

+∞

78.1

H33.0

ICD-10 Finland

Retinal detachment with retinal break

4.2

76.9

307

744

R51.80

ICD-10 Finland

Headache

1.7

76.4

1657

10085

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.5

68.1

251

563

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.2

66.2

751

3585

CEC00

NOMESCO Finland

Recession of extraocular muscle

+∞

65.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

59.7

854

4477

WX140

NOMESCO Finland

Parabulbar anesthesy

3.0

59.1

360

1222

S01ED51

ATC

timolol, combinations; ophthalmic

2.4

57.2

520

2229

114

Kela drug reimbursment

Glaucoma

2.3

56.8

575

2601

CJE40

NOMESCO Finland

Phakoemulsification with implantation of skleralt fixed artificial lens in posterior chamber

122.2

56.7

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.3

56.7

539

2364

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

8.5

56.6

127

151

H51.1

ICD-10 Finland

Convergence insufficiency and excess

190.2

54.9

AA1AD

NOMESCO Finland

CT of head and brain

1.6

53.6

1742

11736

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

53.1

3469

27033

H44.2

ICD-10 Finland

Degenerative myopia

24.2

52.6

37303

ICD-8 Finland

Strabismus, Heterophoria (exophoria, esophroria, hypophoria)

+∞

51.0

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

255.6

50.0

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

49.0

782

4262

H18.6

ICD-10 Finland

Keratoconus

6.5

48.9

130

200

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.8

48.4

324

1169

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

48.2

960

5633

ZXA00

NOMESCO Finland

Right side

1.5

48.2

2114

15193

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.3

48.1

255

785

R42

ICD-10 Finland

Dizziness and giddiness

1.5

46.7

1676

11519

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

46.5

1879

13257

SMILE

NOMESCO Finland

458.0

46.2

CGD99

NOMESCO Finland

Other operation for error of refraction

122.6

45.7

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

45.5

668

3528

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.9

44.6

290

1027

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

94.1

42.7

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.6

42.2

314

1208

3503

FHL

Single muscle retroposition

215.0

41.8

H35.4

ICD-10 Finland

Peripheral retinal degeneration

5.6

41.1

123

221

Z94.7

ICD-10 Finland

Corneal transplant status

10.4

40.9

ZXA05

NOMESCO Finland

Left side

1.4

40.8

1932

14038

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

40.7

438

2035

H25.8

ICD-10 Finland

Other senile cataract

1.9

40.4

593

3132

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

40.0

633

3436

CHC05

NOMESCO Finland

Iridotomy

4.2

39.8

155

370

S01EE01

ATC

latanoprost; ophthalmic

2.3

39.7

391

1745

H26.2

ICD-10 Finland

Complicated cataract

4.4

39.2

147

338

TAB00

NOMESCO Finland

Lumbar puncture

2.2

38.4

430

2034

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

3.0

37.8

224

747

H52

ICD-10 Finland

Disorders of refraction and accommodation

12.9

37.6

N03AX12

ATC

gabapentin; oral

1.5

37.2

1227

8233

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

36.6

2333

17860

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

35.9

2359

18144

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

35.2

362

1649

G44.2

ICD-10 Finland

Tension-type headache

1.5

34.3

1221

8326

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

34.2

2200

16836

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

9.5

33.7

N03AX16

ATC

pregabalin; oral

1.4

33.6

1828

13579

WX002

NOMESCO Finland

Sedation and analgesia

1.5

33.5

1512

10842

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

33.3

1257

8682

N06AX16

ATC

venlafaxine; oral

1.5

33.3

1279

8870

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

33.2

1107

7433

H54.7

ICD-10 Finland

Unspecified visual loss

5.5

33.1

179

H50.9

ICD-10 Finland

Strabismus, unspecified

23.5

33.0

H53.4

ICD-10 Finland

Visual field defects

3.1

32.6

183

591

E0000UV

ATC

1.3

32.5

3735

31149

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

32.3

1047

6981

N06AX11

ATC

mirtazapine; oral

1.3

32.3

2696

21476

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

8.6

31.8

N06AX21

ATC

duloxetine; oral

1.6

31.3

917

5967

XCH00

NOMESCO Finland

Eye pressure measurement

2.3

31.2

301

1331

A02BC05

ATC

esomeprazole; systemic

1.3

30.6

3296

27188

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

30.3

504

2779

F83

ICD-10 Finland

Mixed specific developmental disorders

4.0

30.3

125

316

G47.3

ICD-10 Finland

Sleep apnoea

1.4

30.3

1582

11642

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.3

30.2

280

1215

3670A

ICD-9 Finland

Disorders of refraction and accommodation, Hypermetropia

+∞

30.2

N02AX02

ATC

tramadol; systemic, rectal

1.3

30.2

3295

27219

H40.11

ICD-10 Finland

Low pressure glaucoma

3.4

30.1

152

455

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.4

29.8

260

1094

N06AB04

ATC

citalopram; systemic

1.4

29.8

1753

13174

3507

FHL

Retroposition and resection

302.1

29.8

H02AB09

ATC

hydrocortisone; systemic

2.4

29.7

253

1052

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

29.3

1611

11962

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.5

29.1

227

900

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

28.9

1795

13611

N03AG01

ATC

valproic acid; systemic, rectal

1.8

28.5

545

3147

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

28.2

1199

8469

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

11.8

28.2

S01EC04

ATC

brinzolamide; ophthalmic

2.5

27.9

226

916

S01EE05

ATC

tafluprost; ophthalmic

2.5

27.9

222

891

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

99.9

27.6

Z31.5

ICD-10 Finland

Genetic counselling

1.8

27.6

515

2952

N05BA01

ATC

diazepam; systemic, rectal

1.5

27.4

1042

7191

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

27.4

452

2487

H43.3

ICD-10 Finland

Other vitreous opacities

3.5

27.1

130

375

H02AB06

ATC

prednisolone; systemic

1.3

27.0

3898

33241

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.6

26.9

198

760

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.1

26.9

329

1619

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

27.7

26.6

N05AH04

ATC

quetiapine; oral

1.4

26.5

1513

11288

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

26.4

431

2364

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.9

26.4

166

581

N03AX11

ATC

topiramate; oral

2.2

26.3

264

1191

N05CF01

ATC

zopiclone; oral

1.3

26.2

2349

18807

CEC30

NOMESCO Finland

Resection of extraocular muscle

+∞

26.0

A02BC02

ATC

pantoprazole; systemic

1.2

25.9

5457

48514

N03AX14

ATC

levetiracetam; systemic

2.3

25.8

234

1007

XKD00

NOMESCO Finland

Uroflowmetry

1.5

25.6

864

5804

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

25.6

560

3367

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

25.6

679

4304

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

3.6

25.5

119

336

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

25.5

1918

14963

G35

ICD-10 Finland

Multiple sclerosis

2.8

25.4

170

618

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

25.4

1188

8544

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

25.2

651

4097

R03AC02

ATC

salbutamol; inhalant

1.2

25.1

4947

43589

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

+∞

25.0

3780B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALTERNANS]

+∞

25.0

M79.6

ICD-10 Finland

Pain in limb

1.3

24.9

2977

24741

C07AA05

ATC

propranolol; systemic

1.4

24.9

1702

13077

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

24.9

1802

13970

N03AX09

ATC

lamotrigine; oral

1.8

24.7

464

2664

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

24.6

725

4718

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

24.3

1104

7891

CHD00

NOMESCO Finland

Laser trabeculoplasty

3.9

24.3

102

264

N02BE01

ATC

paracetamol; systemic, rectal

1.3

24.2

8151

76057

UDC00

NOMESCO Finland

Ear microscopy

1.6

24.1

607

3798

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

24.0

282

1365

R4110

NOMESCO Finland

Physiotherapy

1.3

23.9

2109

16817

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.4

23.7

198

815

P85

ICPC

Mental retardation

7.6

23.6

WX110

NOMESCO Finland

Local anesthesy

1.2

23.6

6928

63532

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

23.6

2228

17935

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

2.8

23.4

157

572

SPAT1263

SPAT

Sampling

1.2

23.2

3913

33794

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

2.6

23.1

176

692

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

23.1

3242

27417

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

4.6

23.0

173

S01EC01

ATC

acetazolamide; systemic

2.7

23.0

164

621

N06AA09

ATC

amitriptyline; systemic

1.6

22.9

680

4431

3782B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS DIVERGENS INTERMITTENS]

+∞

22.9

UJF32

NOMESCO Finland

Coloscopy

1.3

22.9

1791

14028

H57.1

ICD-10 Finland

Ocular pain

2.0

22.8

287

1428

R06.0

ICD-10 Finland

Dyspnoea

1.3

22.8

1804

14155

CJE99

NOMESCO Finland

Other extracapsular cataract operation using phakoemulsification technique

15.4

22.7

TCG10

NOMESCO Finland

Removal of sutures from cornea

5.9

22.6

106

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

22.5

668

4352

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

7.2

22.3

UKC02

NOMESCO Finland

Cystoscopy

1.4

22.1

946

6680

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

2.7

22.1

154

576

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

22.1

1315

9860

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

22.0

740

4964

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

21.9

1862

14747

N03AE01

ATC

clonazepam; systemic

1.7

21.9

438

2564

3672A

ICD-9 Finland

Disorders of refraction and accommodation, Astigmatism

+∞

21.8

CEW99

NOMESCO Finland

Other operation on extraocular muscle

+∞

21.8

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.1

21.8

211

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

21.8

444

2618

A02BA02

ATC

ranitidine; systemic

1.4

21.7

1307

9819

S01ED01

ATC

timolol; ophthalmic

2.3

21.6

210

935

183

Kela drug reimbursment

Lamotrigin and topiramate

3.1

21.5

120

389

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

14.4

21.5

R62.0

ICD-10 Finland

Delayed milestone

3.4

21.3

106

316

N05CF02

ATC

zolpidem; oral

1.4

21.3

1398

10644

H47.2

ICD-10 Finland

Optic atrophy

6.1

21.3

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

4.7

21.2

153

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

21.1

2338

19179

A02BC03

ATC

lansoprazole; oral

1.3

20.9

2117

17158

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.4

20.9

940

6702

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

4.0

20.8

211

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

+∞

20.8

J02AC01

ATC

fluconazole; systemic

1.2

20.7

3612

31203

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

3.1

20.6

112

357

XKC03

NOMESCO Finland

Water cystometry

2.1

20.5

235

1128

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.6

20.4

150

577

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

20.4

872

6152

N05BA04

ATC

oxazepam; oral

1.3

20.4

1988

16023

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

20.2

1071

7865

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

6.0

20.2

CS494

NOMESCO Finland

Other visual field testing

2.5

20.1

163

664

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

20.0

3901

34053

L17

ICPC

Foot/toe symptom/complaint

1.3

20.0

2058

16707

SPAT1301

SPAT

No procedures

1.2

20.0

2685

22517

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

19.9

705

4781

R53

ICD-10 Finland

Malaise and fatigue

1.3

19.8

1619

12738

N03AF02

ATC

oxcarbazepine; oral

2.0

19.7

268

1379

R4120

NOMESCO Finland

Occupational therapy

1.6

19.7

497

3108

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

19.7

705

4796

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

2.0

19.6

260

1322

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

19.5

625

4149

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.6

19.4

145

566

K07.60

ICD-10 Finland

Snapping jaw

1.6

19.3

454

2789

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

19.3

3808

33248

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

19.2

286

1520

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.6

19.2

451

2768

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

19.0

2651

22298

H16.0

ICD-10 Finland

Corneal ulcer

1.7

18.9

377

2209

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

18.9

817

5776

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.7

18.8

128

472

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

27.7

18.6

R11

ICD-10 Finland

Nausea and vomiting

1.5

18.6

637

4292

H50.8

ICD-10 Finland

Other specified strabismus

99.8

18.5

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

18.5

3837

33631

R06.5

ICD-10 Finland

Mouth breathing

1.5

18.4

673

4598

N05BA09

ATC

clobazam; oral

3.5

18.3

237

R06AE07

ATC

cetirizine; oral

1.2

18.3

4102

36214

H53.3

ICD-10 Finland

Other disorders of binocular vision

5.2

18.3

107

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.4

18.2

269

M03BX02

ATC

tizanidine; oral

1.2

18.2

5520

50114

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.3

18.2

160

G04BD12

ATC

mirabegron; oral

1.5

18.2

569

3757

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

24.9

18.1

F05

ICPC

Visual disturbance other

2.1

18.1

216

1057

A98

ICPC

Health maint/preventive medicine

1.5

18.1

10466

101863

CKC60

NOMESCO Finland

Local buckling of sclera using implant

5.3

18.1

104

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

18.0

1386

10799

R35

ICD-10 Finland

Polyuria

1.7

17.9

398

2404

37929

ICD-8 Finland

Blindness, one eye, specifically defined

32.8

17.9

R01AD09

ATC

mometasone; nasal

1.2

17.9

4137

36601

A02BC01

ATC

omeprazole; systemic

1.3

17.9

2026

16617

H03AA01

ATC

levothyroxine sodium; systemic

1.3

17.8

1806

14609

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

17.8

1994

16330

F29

ICPC

Eye symptom/complaint other

1.5

17.8

674

4641

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.0

17.7

100

329

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

17.7

899

6547

SPAT1260

SPAT

Consultation of another employee

1.3

17.7

1430

11214

602

Kela drug reimbursment

Children's severe malnutrition

3.7

17.7

208

M25.5

ICD-10 Finland

Pain in joint

1.2

17.6

2375

19878

H54.5

ICD-10 Finland

Severe visual impairment, monocular

6.0

17.5

L03AX13

ATC

glatiramer acetate; parenteral

4.6

17.5

134

TCG30

NOMESCO Finland

Imaging of anterior and posterior part of cornea

9.7

17.5

R51

ICD-10 Finland

Headache

1.6

17.5

461

2916

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

17.5

607

4101

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

17.5

564

3750

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

17.3

817

5877

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.5

17.3

233

SPAT1310

SPAT

Counselling related to known health issue

1.2

17.1

2851

24392

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

17.1

548

3637

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.1

17.1

304

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.6

17.1

123

471

L04AX01

ATC

azathioprine; systemic

1.7

17.0

359

2142

L01

ICPC

Neck symptom/complaint

1.3

17.0

1102

8361

R55

ICD-10 Finland

Syncope and collapse

1.5

16.9

682

4756

S01AX11

ATC

[U] ofloxacin; ophthalmic

1.9

16.8

238

1248

109

Kela drug reimbursment

Multiple sclerosis

2.7

16.7

117

442

3781B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]

+∞

16.6

S01EE03

ATC

bimatoprost; ophthalmic

2.4

16.6

137

566

R06AX27

ATC

desloratadine; oral

1.2

16.6

2602

22114

3504

FHL

Retroposition of two muscles

169.6

16.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

16.4

348

2078

H46

ICD-10 Finland

Optic neuritis

2.9

16.4

330

H17.8

ICD-10 Finland

Other corneal scars and opacities

6.3

16.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

16.4

2622

22323

Q87.4

ICD-10 Finland

Marfan syndrome

8.5

16.3

R03DC03

ATC

montelukast; oral

1.3

16.3

1342

10548

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

16.2

680

4780

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.5

16.2

534

3565

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

16.2

1509

12062

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

16.1

375

2297

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

16.1

1276

9975

H02.4

ICD-10 Finland

Ptosis of eyelid

2.1

16.1

174

816

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

2.8

16.0

100

353

R50.9

ICD-10 Finland

Fever, unspecified

1.3

16.0

1139

8765

J45

ICD-10 Finland

Asthma

1.4

15.9

744

5337

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

15.9

764

5509

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

15.9

1491

11923

N06AB10

ATC

escitalopram; oral

1.3

15.9

1796

14702

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

15.9

189

924

WX142

NOMESCO Finland

Sub-tenon anesthesy

4.9

15.8

104

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

15.8

472

3083

K59.0

ICD-10 Finland

Constipation

1.6

15.7

368

2259

M79.1

ICD-10 Finland

Myalgia

1.3

15.7

1018

7719

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

15.7

923

6893

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

15.7

538

3625

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

2.4

15.6

134

566

3783A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia

+∞

15.6

H33.5

ICD-10 Finland

Other retinal detachments

3.7

15.6

185

CG2S4

NOMESCO Finland

Photography of cornea

5.3

15.6

CG2Z4

NOMESCO Finland

Specialised imaging of cornea

9.7

15.6

A06AD11

ATC

lactulose; oral

1.4

15.5

830

6103

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

15.5

1364

10816

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

15.4

784

5711

CKC30

NOMESCO Finland

Cryopexy of detached retina

4.8

15.4

107

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

15.4

2921

25265

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.7

15.4

307

1802

H01AC01

ATC

somatropin; parenteral

3.4

15.4

213

F28

ICPC

Limited function/disability (F)

4.2

15.4

139

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.2

15.3

256

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.1

15.3

173

829

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

15.3

1901

15730

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.5

15.2

199

L04AD01

ATC

ciclosporin; systemic

2.2

15.2

159

738

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

15.2

666

4723

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.1

15.1

167

794

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

15.1

492

3280

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

15.0

400

2542

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

15.0

1614

13120

3716A

ICD-9 Finland

Corneal opacity and other disorders of cornea, Keratoconus

20.0

15.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

15.0

1509

12169

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

15.0

375

2345

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

15.0

380

2387

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

15.0

663

4710

R01AD12

ATC

fluticasone furoate; nasal

1.2

14.9

2765

23854

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

14.9

1321

10483

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

2.9

14.8

307

M41.4

ICD-10 Finland

Neuromuscular scoliosis

9.4

14.8

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

14.7

333

2026

H53.8

ICD-10 Finland

Other visual disturbances

2.7

14.7

361

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

14.7

3084

26907

S01FA01

ATC

atropine; ophthalmic

4.7

14.7

104

G43.3

ICD-10 Finland

Complicated migraine

2.1

14.7

159

748

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

14.7

4925

44755

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

14.7

1104

8563

L04AA06

ATC

mycophenolic acid; systemic

2.2

14.6

144

650

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

14.6

2127

17897

H02.3

ICD-10 Finland

Blepharochalasis

1.6

14.6

363

2269

CJA00

NOMESCO Finland

Implantation of phakic lens in anterior chamber

+∞

14.6

BE00A

NOMESCO Finland

14.1

14.5

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

14.4

404

2597

37003

ICD-8 Finland

Refractive errors, Anisometropia

149.6

14.4

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

10.0

14.4

A11

ICPC

Chest pain NOS

1.5

14.3

467

3113

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.5

14.3

115

470

J01FA10

ATC

azithromycin; systemic

1.2

14.3

5887

54352

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

14.2

601

4231

SPAT1153

SPAT

Removal of sutures

1.2

14.2

2322

19771

L08

ICPC

Shoulder symptom/complaint

1.3

14.2

1325

10584

127

Kela drug reimbursment

Transplant complication

2.3

14.1

127

550

J01DB01

ATC

cefalexin; oral

1.2

14.1

8013

75922

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

14.1

2764

23946

S06.0

ICD-10 Finland

Concussion

1.4

14.1

841

6295

WX199

NOMESCO Finland

Other local analgesia

2.0

14.1

167

819

R05

ICD-10 Finland

Cough

1.3

14.1

1496

12143

L28

ICPC

Limited function/disability (L)

1.3

13.9

903

6854

R03BA05

ATC

fluticasone; inhalant

1.3

13.8

1521

12391

CJF50

NOMESCO Finland

Removal and implantation of artificial lens in posterior chamber

29.9

13.8

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

13.8

375

2398

N01

ICPC

Headache

1.3

13.8

1148

9029

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

13.8

4514

40870

J05AB01

ATC

aciclovir; systemic

1.2

13.7

1633

13426

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

13.7

355

2242

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

7.3

13.6

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

13.6

615

4387

WX402

NOMESCO Finland

General anaesthesia

1.3

13.6

1352

10885

M03BX01

ATC

baclofen; systemic

2.2

13.5

129

576

3673A

ICD-9 Finland

Disorders of refraction and accommodation, Anisometropia and aniseikonia

+∞

13.5

CEC20

NOMESCO Finland

Recession and advancement of extraocular muscle

+∞

13.5

N06AB03

ATC

fluoxetine; oral

1.3

13.5

985

7600

R01AD01

ATC

beclometasone; nasal

1.3

13.4

1146

9045

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.9

13.2

188

987

R13

ICD-10 Finland

Dysphagia

1.5

13.2

398

2609

S01EE04

ATC

travoprost; ophthalmic

2.3

13.1

114

488

J01MA02

ATC

ciprofloxacin; systemic

1.2

13.0

2821

24629

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

13.0

1443

11761

M54.5

ICD-10 Finland

Low back pain

1.2

13.0

2709

23574

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

12.9

250

1459

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

12.9

1002

7804

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

3.2

12.9

206

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.9

12.9

255

WX892

NOMESCO Finland

Monitored bed care

1.5

12.8

501

3472

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

12.8

876

6699

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.4

12.7

679

4989

M54.2

ICD-10 Finland

Cervicalgia

1.4

12.7

517

3614

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

12.7

309

1923

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

6.2

12.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

12.6

7058

66393

H01

ICPC

Ear pain/earache

1.3

12.6

987

7692

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

12.6

743

5549

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

4.7

12.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

12.6

638

4646

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.2

12.6

129

595

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

12.5

1859

15644

C09CA06

ATC

candesartan; oral

1.2

12.5

1461

11978

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

2.5

12.5

371

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

12.5

546

3868

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

12.5

399

2652

3781A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS CONCOMITANS DIVERGENS]

+∞

12.5

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

12.5

2326

20023

S01BC03

ATC

diclofenac; ophthalmic

2.0

12.4

156

784

37600

ICD-8 Finland

Detachment of retina, Primaria

13.1

12.4

SPAT1312

SPAT

General health counselling

1.2

12.3

3028

26709

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

12.2

355

2308

N03AF01

ATC

carbamazepine; oral, rectal

1.6

12.2

314

1982

N06AB06

ATC

sertraline; oral

1.3

12.2

915

7086

RL140

NOMESCO Finland

4.9

12.2

Q85.1

ICD-10 Finland

Tuberous sclerosis

14.3

12.2

S18

ICPC

Laceration/cut

1.2

12.2

3194

28313

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

12.2

791

5997

WX720

NOMESCO Finland

Own respiration

1.7

12.2

257

1536

J05AB11

ATC

valaciclovir; oral

1.3

12.2

952

7415

Z94.0

ICD-10 Finland

Kidney transplant status

2.5

12.2

365

R02

ICPC

Shortness of breath/dyspnoea

1.3

12.2

842

6448

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

12.2

3545

31700

SPAT1262

SPAT

Handing over of treatment supplies

1.3

12.1

1159

9274

L03

ICPC

Low back symptom/complaint

1.2

12.1

1944

16488

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

12.1

367

2412

SPAT1325

SPAT

Vaccination

1.2

12.1

2712

23724

CE2W4

NOMESCO Finland

Eye movement mapping

12.3

12.1

A03FA02

ATC

cisapride; oral, rectal

1.5

12.0

475

3300

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

12.0

3341

29752

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

12.0

264

1598

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

12.0

369

2431

L04AA31

ATC

teriflunomide; oral

4.6

12.0

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

12.0

793

6030

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

12.0

1919

16265

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

12.0

311

1965

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

12.0

532

3784

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

12.0

2881

25351

J01CA04

ATC

amoxicillin; systemic

1.2

11.9

8381

80058

F32.1

ICD-10 Finland

Moderate depressive episode

1.4

11.9

492

3450

Q12.0

ICD-10 Finland

Congenital cataract

9.2

11.9

J20

ICD-10 Finland

Acute bronchitis

1.4

11.9

669

4957

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.7

11.9

261

1581

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

4.0

11.8

115

H66.9

ICD-10 Finland

Otitis media, unspecified

1.4

11.8

625

4588

R52.2

ICD-10 Finland

Other chronic pain

1.7

11.8

227

1324

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

11.8

456

3159

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.3

11.8

105

455

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.1

11.8

133

640

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.5

11.8

353

SPAT1211

SPAT

Application of soft bandage

1.4

11.8

702

5253

M01AE02

ATC

naproxen; oral, rectal

1.2

11.7

5347

49405

J01FF01

ATC

clindamycin; systemic

1.2

11.7

2060

17620

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

10.5

11.7

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

11.7

350

2292

RT274

NOMESCO Finland

5.6

11.7

C07AB07

ATC

bisoprolol; oral

1.2

11.6

2986

26403

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

11.6

464

3232

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

11.6

384

2571

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

3.6

11.6

137

M54.1

ICD-10 Finland

Radiculopathy

1.7

11.6

253

1531

H50

ICD-10 Finland

Other strabismus

64.8

11.6

3604

FHL

Penetration of the cornea

12.5

11.6

H17.1

ICD-10 Finland

Other central corneal opacity

6.0

11.6

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

6.0

11.6

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

11.5

515

3666

RS220

NOMESCO Finland

2.2

11.5

117

540

N99

ICPC

Neurological disease other

2.6

11.5

328

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

2.5

11.5

354

3505

FHL

Single muscle resection

+∞

11.4

CEC50

NOMESCO Finland

Advancement of extraocular muscle

+∞

11.4

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

11.4

223

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

11.4

161

845

G04BD08

ATC

solifenacin; oral

1.5

11.4

353

2329

D07AC01

ATC

betamethasone; topical

1.2

11.3

2614

22897

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

11.3

470

3301

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

11.3

253

1542

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

6.9

11.3

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

4.2

11.2

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

11.2

616

4551

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.3

11.2

101

440

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

8.8

11.2

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

6.5

11.2

181

Kela drug reimbursment

Retigabine and vigabatrin

7.2

11.2

-1

NOMESCO Finland

1.2

11.2

3313

29618

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

11.0

1114

8973

N06AB05

ATC

paroxetine; oral

1.4

11.0

446

3117

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

3.1

11.0

186

N03AG04

ATC

vigabatrin; oral

6.4

11.0

H27.8

ICD-10 Finland

Other specified disorders of lens

6.4

11.0

D01

ICPC

Abdominal pain/cramps general

1.3

11.0

944

7447

H26.9

ICD-10 Finland

Cataract, unspecified

2.6

11.0

308

A01

ICPC

Pain general/multiple sites

1.4

11.0

519

3735

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.5

10.9

315

2050

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

10.9

812

6285

S01BC05

ATC

ketorolac; ophthalmic

1.8

10.9

188

1062

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

10.9

234

1411

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

10.9

701

5313

G04CA01

ATC

alfuzosin; oral

1.4

10.9

519

3742

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.9

10.8

148

771

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

10.8

137

695

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

10.7

262

1636

S01EA03

ATC

apraclonidine; ophthalmic

2.9

10.7

212

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.8

10.7

188

1070

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

10.6

838

6534

H93.1

ICD-10 Finland

Tinnitus

1.5

10.6

418

2905

WX723

NOMESCO Finland

CPAP therapy

1.7

10.6

228

1375

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

10.6

561

4117

L03AB07

ATC

interferon beta-1a; parenteral

3.0

10.6

192

J01FA09

ATC

clarithromycin; systemic

1.2

10.5

2722

24048

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

10.5

378

2583

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

6.9

10.5

XF602

NOMESCO Finland

Bloodpressure monitoring

2.5

10.5

326

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

10.5

301

1955

K03.00

ICD-10 Finland

Approximal wear

1.5

10.5

370

2517

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

10.5

230

1397

S01AD03

ATC

aciclovir; ophthalmic

1.6

10.4

238

1458

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

10.4

906

7158

P01BA02

ATC

hydroxychloroquine; oral

1.4

10.4

564

4158

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

10.3

420

2938

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

10.3

697

5317

G03DB01

ATC

dydrogesterone; oral

1.3

10.3

1054

8497

N06BA04

ATC

methylphenidate; oral

1.6

10.3

240

1479

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

16.0

10.3

H81

ICPC

Excessive ear wax

1.3

10.3

921

7305

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.5

10.3

324

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

12.0

10.3

H26.3

ICD-10 Finland

Drug-induced cataract

3.2

10.3

168

XQ800

NOMESCO Finland

Prick test

1.3

10.3

660

4996

H02AB07

ATC

prednisone; oral

1.3

10.2

938

7466

P06

ICPC

Sleep disturbance

1.3

10.2

759

5872

N17

ICPC

Vertigo/dizziness

1.3

10.2

722

5545

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

8.7

10.2

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

10.2

271

1727

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

3.5

10.2

127

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

4.4

10.1

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.7

10.1

223

1354

SPAT1009

SPAT

Measurement of intraocular pressure

2.3

10.1

378

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

10.1

625

4708

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

10.1

804

6281

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

10.1

585

4362

XF404

NOMESCO Finland

Ambulatory ECG

1.4

10.1

569

4222

J01AA02

ATC

doxycycline; systemic

1.1

10.1

6757

63804

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

10.0

372

2556

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.0

10.0

116

567

R52.9

ICD-10 Finland

Pain, unspecified

1.4

10.0

574

4267

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.0

10.0

188

J01MA12

ATC

levofloxacin; systemic

1.2

10.0

1147

9372

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

10.0

2867

25517

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.8

10.0

165

917

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.5

10.0

288

1873

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

10.0

142

753

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

10.0

210

1260

H18.7

ICD-10 Finland

Other corneal deformities

9.1

10.0

RT490

NOMESCO Finland

6.4

10.0

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

9.9

1864

16016

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.0

9.9

192

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

9.9

451

3224

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

9.9

689

5281

DFF20

NOMESCO Finland

Audiometry for children

3.5

9.9

130

Z71.8

ICD-10 Finland

Other specified counselling

1.2

9.9

2074

17994

U02

ICPC

Urinary frequency/urgency

1.3

9.9

956

7659

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.0

9.9

130

667

L03AB08

ATC

interferon beta-1b; parenteral

4.2

9.9

H16.9

ICD-10 Finland

Keratitis, unspecified

2.0

9.9

122

615

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

9.8

461

3316

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

9.8

1387

11593

B03XA01

ATC

erythropoietin; parenteral

2.9

9.8

195

CHD35

NOMESCO Finland

Laser goniopuncture

4.3

9.8

FM2CE

NOMESCO Finland

2.2

9.8

444

H27.1

ICD-10 Finland

Dislocation of lens

5.0

9.8

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.1

9.8

5008

46407

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

9.8

487

3540

RT190

NOMESCO Finland

8.1

9.8

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.0

9.7

127

652

SPAT1097

SPAT

Recording of ECG

1.3

9.7

877

6964

H18.4

ICD-10 Finland

Corneal degeneration

4.4

9.7

R1250

NOMESCO Finland

Evaluation of functional capability

1.8

9.7

149

809

WX704

NOMESCO Finland

Intubation

1.4

9.7

482

3499

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

9.7

639

4856

N06AX12

ATC

bupropion; oral

1.4

9.7

530

3912

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.2

9.7

439

R03BA01

ATC

beclometasone; inhalant

1.3

9.7

972

7824

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

7.3

9.6

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

9.6

117

584

WX882

NOMESCO Finland

High dependency care

1.7

9.6

211

1281

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.7

9.6

211

1283

K03.66

ICD-10 Finland

Tooth plaque

1.4

9.6

519

3827

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.3

9.6

391

KMAK

NOMESCO Finland

1.1

9.5

4760

44010

F84.5

ICD-10 Finland

Asperger syndrome

2.5

9.5

271

M02AA07

ATC

piroxicam; topical

1.2

9.5

2507

22150

R03AC03

ATC

terbutaline; inhalant

1.2

9.5

1077

8790

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

9.5

800

6295

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

9.5

1047

8517

CKC65

NOMESCO Finland

Removal of buckling implant from sclera

11.3

9.5

D06

ICPC

Abdominal pain localized other

1.3

9.5

632

4814

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

9.5

491

3593

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

9.5

450

3245

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

10.0

9.5

H02AB04

ATC

methylprednisolone; systemic

1.3

9.5

982

7933

C07AB02

ATC

metoprolol; systemic

1.2

9.5

1123

9215

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

5.9

9.4

R03BA02

ATC

budesonide; inhalant

1.2

9.4

1377

11548

M48.0

ICD-10 Finland

Spinal stenosis

1.3

9.4

620

4715

H52.6

ICD-10 Finland

Other disorders of refraction

99.7

9.4

N02CC03

ATC

zolmitriptan; nasal, oral

1.4

9.4

420

2996

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.5

9.4

349

2402

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

9.4

524

3885

C08CA01

ATC

amlodipine; oral

1.2

9.4

2028

17633

C10AC01

ATC

colestyramine; oral

1.8

9.4

167

956

G40.10

ICD-10 Finland

Simple partial seizures

2.6

9.3

251

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

3.5

9.3

116

N05AX08

ATC

risperidone; systemic

1.4

9.3

503

3706

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

9.3

1469

12413

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.8

9.3

150

832

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

9.3

450

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

2.4

9.2

318

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

9.2

2309

20320

M79.7

ICD-10 Finland

Fibromyalgia

1.6

9.2

241

1534

F01

ICPC

Eye pain

1.6

9.2

205

1252

VALMI

NOMESCO Finland

1.2

9.1

2389

21085

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

9.1

815

6464

E000001

ATC

1.2

9.1

1720

14774

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.8

9.1

163

933

D02

ICPC

Abdominal pain epigastric

1.4

9.1

420

3013

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

9.1

1177

9749

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

9.1

342

2360

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.3

9.1

565

4262

RS221

NOMESCO Finland

2.0

9.0

117

599

G04BD07

ATC

tolterodine; oral

1.6

9.0

246

1582

3619

FHL

Other operations in this group, such as corneal refractive surgery

15.5

9.0

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

36.6

9.0

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

9.0

730

5722

CKC70

NOMESCO Finland

Circular buckling of sclera

4.4

8.9

R06AX22

ATC

ebastine; oral

1.2

8.9

1338

11243

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.3

8.9

358

J01FA06

ATC

roxithromycin; oral

1.1

8.9

3146

28375

N02CD01

ATC

erenumab; parenteral

2.4

8.9

319

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

1.9

8.9

131

704

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

8.9

292

1956

SPAT1053

SPAT

Memory test

1.3

8.9

608

4646

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

8.9

929

7506

F93.89

ICD-10 Finland

Other childhood emotional disorders

2.0

8.9

116

595

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

8.9

211

1310

R30.0

ICD-10 Finland

Dysuria

1.6

8.9

246

1585

H52.7

ICD-10 Finland

Disorder of refraction, unspecified

18.5

8.9

A28

ICPC

Limited function/disability NOS

1.3

8.9

705

5507

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

8.9

585

4449

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

2.3

8.8

333

A02BC04

ATC

rabeprazole; oral

1.3

8.8

568

4306

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

3.3

8.8

132

F79

ICD-10 Finland

Unspecified mental retardation

12.5

8.8

Q87.80

ICD-10 Finland

Alport syndrome

12.5

8.8

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.1

8.8

3114

28092

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

8.8

445

3248

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

8.7

2573

22915

B07.9

ICD-10 Finland

Verruca simplex

1.5

8.7

265

1749

X58

ICD-10 Finland

Exposure to other specified factors

1.2

8.7

1074

8853

C01CA24

ATC

epinephrine; parenteral

1.3

8.7

526

3951

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

2.6

8.7

223

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

4.0

8.7

R05

ICPC

Cough

1.2

8.6

1820

15777

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

8.6

495

3688

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

8.6

2166

19054

J01MA06

ATC

norfloxacin; oral

1.3

8.6

862

6937

S01EC54

ATC

brinzolamide, combinations; ophthalmic

2.5

8.6

257

H26.01

ICD-10 Finland

Infantile, juvenile and presenile cataract

7.6

8.6

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.1

8.6

5030

46857

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

8.6

422

3063

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

2.4

8.6

276

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

8.6

1625

13962

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

8.5

524

3942

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

2.1

8.5

445

C03CA01

ATC

furosemide; systemic

1.2

8.5

1365

11543

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

8.5

254

1668

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

2.5

8.5

244

M35.7

ICD-10 Finland

Hypermobility syndrome

1.9

8.5

119

628

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.5

8.5

255

1680

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.3

8.5

502

3761

J45.1

ICD-10 Finland

Nonallergic asthma

1.3

8.5

503

3766

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

8.5

4406

40738

J01EA01

ATC

trimethoprim; systemic

1.2

8.4

1900

16563

N06AX05

ATC

trazodone; oral

1.7

8.4

181

1095

L04AA01

ATC

[U] ciclosporin; systemic

2.0

8.4

489

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

8.4

248

1625

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.6

8.4

212

Q85.9

ICD-10 Finland

Phakomatosis, unspecified

89.8

8.4

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

89.8

8.4

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

8.4

392

2822

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.3

8.4

849

6842

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

8.4

573

4385

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

3.9

8.4

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.6

8.4

213

1348

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.6

8.4

L16

ICPC

Ankle symptom/complaint

1.3

8.4

796

6366

H47.1

ICD-10 Finland

Papilloedema, unspecified

2.9

8.3

171

XF402

NOMESCO Finland

ECG with work load test

1.3

8.3

623

4826

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

8.3

464

3443

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

+∞

8.3

H50.6

ICD-10 Finland

Mechanical strabismus

+∞

8.3

3745

FHL

Hard membrane girding, cerclage with coagulation

7.8

8.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

8.3

171

1021

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

8.3

978

8015

ICD-10 Finland

1.8

8.3

133

735

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.3

8.3

307

U04

ICPC

Incontinence urine

1.5

8.3

231

1496

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

3.5

8.3

102

G04CA02

ATC

tamsulosin; oral

1.2

8.2

941

7687

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

8.2

269

1807

-31

ICPC

Medical examin/health eval partial

1.3

8.2

507

3820

K30

ICD-10 Finland

Functional dyspepsia

1.3

8.2

718

5684

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.4

8.2

342

2414

Q05.2

ICD-10 Finland

Lumbar spina bifida with hydrocephalus

14.4

8.2

N05CD07

ATC

temazepam; oral

1.3

8.1

642

5011

XW000

NOMESCO Finland

Bone marrow biopsy

1.6

8.1

220

1414

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

2.5

8.1

240

L05

ICPC

Flank/axilla symptom/complaint

1.4

8.1

345

2441

A05

ICPC

Feeling ill

1.3

8.1

638

4981

CD2S4

NOMESCO Finland

Photography of eye

3.4

8.1

109

L21.0

ICD-10 Finland

Seborrhoea capitis

2.3

8.1

324

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

8.1

471

3520

CKD60

NOMESCO Finland

Anterior vitrectomy

3.1

8.1

136

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

8.0

1382

11763

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.0

8.0

452

R51.81

ICD-10 Finland

Facial pain NOS

1.7

8.0

151

880

S29

ICPC

Skin symptom/complaint other

1.2

8.0

1206

10140

N05BA12

ATC

alprazolam; oral

1.3

8.0

675

5314

H26.1

ICD-10 Finland

Traumatic cataract

4.1

8.0

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.4

8.0

366

2627

H26.8

ICD-10 Finland

Other specified cataract

2.9

8.0

157

SAA02

NOMESCO Finland

Basic examination of mouth

1.1

8.0

6568

62319

R4130

NOMESCO Finland

Speech therapy

1.8

8.0

138

786

P29

ICPC

Psychological sympt/compl other

1.3

8.0

517

3925

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

8.0

347

2467

N02CC04

ATC

rizatriptan; oral

1.4

7.9

450

3348

J01DA01

ATC

[U] cefalexin; systemic

1.1

7.9

5487

51523

L04AB06

ATC

golimumab; parenteral

2.3

7.9

293

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

7.9

418

3075

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.6

7.9

205

1304

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

7.9

157

931

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.2

7.9

890

7260

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

4.7

7.9

N06AX26

ATC

vortioxetine; oral

1.4

7.9

437

3240

D12

ICPC

Constipation

1.6

7.9

177

1086

SPAT1229

SPAT

Assessment of need for aid

1.4

7.9

410

3007

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

7.9

264

1782

H26.00

ICD-10 Finland

Infantile, juvenile and presenile cataract

13.0

7.8

-48

ICPC

Clarification/discussion RFE/demand

1.5

7.8

237

1565

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

3.1

7.8

134

A11CC03

ATC

alfacalcidol; systemic

1.8

7.8

135

769

M01AH02

ATC

rofecoxib; oral

1.3

7.8

739

5908

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.9

7.8

105

547

L04AA13

ATC

leflunomide; oral

1.7

7.8

158

944

S01EC03

ATC

dorzolamide; ophthalmic

2.3

7.8

278

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.3

7.8

278

U05

ICPC

Urination problems other

1.5

7.8

232

1528

SPAT1139

SPAT

Nutrition survey

1.6

7.8

210

1349

XX4AW

NOMESCO Finland

2.8

7.8

162

XCD20

NOMESCO Finland

Photoangiography of eye

2.0

7.8

458

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.3

7.8

547

4207

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

4.3

7.8

Q25.0

ICD-10 Finland

Patent ductus arteriosus

3.3

7.7

108

M02AA10

ATC

ketoprofen; topical

1.2

7.7

1015

8419

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

7.7

1286

10918

Z94.4

ICD-10 Finland

Liver transplant status

3.2

7.7

114

N86

ICPC

Multiple sclerosis

2.7

7.7

179

H35.36

ICD-10 Finland

Macular cyst

3.0

7.7

136

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.6

7.7

203

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

7.7

1144

9611

SPAT1254

SPAT

Administration of medicine

1.2

7.7

1124

9424

N29

ICPC

Neurological sympt/complt other

1.9

7.7

112

602

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.8

7.6

120

663

R01AD08

ATC

fluticasone; nasal

1.1

7.6

2319

20667

RS311

NOMESCO Finland

3.4

7.6

Q87.8

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

24.9

7.5

F95

ICPC

Strabismus

11.8

7.5

N03AX18

ATC

lacosamide; systemic

2.4

7.5

242

137

Kela drug reimbursment

Uraemia requiring dialysis

2.4

7.5

251

G44.0

ICD-10 Finland

Cluster headache syndrome

2.0

7.5

411

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

2.4

7.5

233

M01AH01

ATC

celecoxib; oral (coxibs)

1.2

7.5

1134

9536

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.7

7.5

148

878

N05AH03

ATC

olanzapine; systemic

1.3

7.5

452

3397

Z83.5

ICD-10 Finland

Family history of eye and ear disorders

5.4

7.5

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

2.6

7.5

191

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.5

7.5

246

1655

-50

ICPC

Medication/prescr/renewal

1.5

7.5

249

1680

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

7.5

880

7216

RT150

NOMESCO Finland

2.8

7.5

155

A04

ICPC

Weakness/tiredness general

1.2

7.5

999

8300

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

3.2

7.4

117

BC00A

NOMESCO Finland

7.1

7.4

S21

ICPC

Skin texture symptom/complaint

1.2

7.4

847

6919

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

1.9

7.4

102

536

CA1ME

NOMESCO Finland

Ultrasound oculometry

2.9

7.4

149

A07AA02

ATC

nystatin; oral

1.4

7.4

345

2483

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.8

7.4

110

598

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

7.4

441

3313

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.3

7.4

471

3574

N05AX12

ATC

aripiprazole; systemic

1.4

7.4

322

2293

A01AB09

ATC

miconazole; local oral

1.3

7.3

561

4367

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.8

7.3

115

634

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.1

7.3

354

SCD02

NOMESCO Finland

Removal of tooth plaque or tartar

2.3

7.3

261

M13.9

ICD-10 Finland

Arthritis, unspecified

1.3

7.3

458

3466

3784B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Heterophoria[EXOPHORIA]

+∞

7.3

H50.3

ICD-10 Finland

Intermittent heterotropia

+∞

7.3

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.8

7.3

121

683

M05BA04

ATC

alendronic acid; oral

1.4

7.3

369

2698

R07.3

ICD-10 Finland

Other chest pain

1.3

7.3

570

4447

E03

ICD-10 Finland

Other hypothyroidism

1.4

7.3

365

2666

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.0

7.3

429

J46

ICD-10 Finland

Status asthmaticus

1.6

7.3

171

1065

Q87.09

ICD-10 Finland

Other congenital malformations that mainly affect the appearance of the face

10.8

7.3

CJF20

NOMESCO Finland

Removal of artificial lens

10.8

7.3

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

1.9

7.3

508

L57.0

ICD-10 Finland

Actinic keratosis

1.4

7.3

406

3016

J01DA06

ATC

[U] cefuroxime; systemic

1.2

7.3

1056

8848

3744

FHL

Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)

6.8

7.2

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.8

7.2

115

640

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.3

7.2

421

3149

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.5

7.2

208

1361

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.4

7.2

293

2062

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

1.9

7.2

102

545

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

2.4

7.2

227

P07.2

ICD-10 Finland

Extreme immaturity

7.3

7.1

H27.0

ICD-10 Finland

Aphakia

4.6

7.1

ZX120

NOMESCO Finland

Intravenous

1.3

7.1

590

4637

P01AB01

ATC

metronidazole; oral, rectal

1.1

7.1

3173

28977

3046

Kela drug reimbursment

29.9

7.1

E70.3

ICD-10 Finland

Albinism

29.9

7.1

353

Kela drug reimbursment

Cladribine and fingolimod

3.4

7.1

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.1

7.1

377

104

Kela drug reimbursment

Thyroid insufficiency

1.3

7.1

433

3260

7410D

ICD-9 Finland

Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG LUMBALIS]

19.9

7.1

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

19.9

7.1

H50.4

ICD-10 Finland

Other and unspecified heterotropia

19.9

7.1

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

2.3

7.1

259

R60.0

ICD-10 Finland

Localized oedema

1.3

7.1

614

4857

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.5

7.1

222

1481

-44

ICPC

Preventive immunization/medic

1.3

7.0

515

3984

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

4.0

7.0

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

7.0

1034

8673

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.4

7.0

234

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

8.7

7.0

H17.0

ICD-10 Finland

Adherent leukoma

10.0

7.0

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.0

7.0

422

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

3.3

7.0

101

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.3

7.0

243

TKC22

NOMESCO Finland

Catheterisation instruction

1.9

7.0

531

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

3.1

7.0

112

D02AX

ATC

Other emollients and protectives

1.4

7.0

269

1873

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

2.1

7.0

362

E000006

ATC

1.3

7.0

477

3658

S01GX05

ATC

lodoxamide; ophthalmic

1.9

7.0

492

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.5

6.9

228

1538

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

4.1

6.9

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.8

6.9

110

611

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

1.9

6.9

480

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.3

6.9

256

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

6.9

602

4767

RT271

NOMESCO Finland

3.9

6.9

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.9

6.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.4

6.9

351

2567

D07AC13

ATC

mometasone; topical

1.1

6.9

2163

19307

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.7

6.9

128

747

R5599

NOMESCO Finland

Other rehabilitation service

1.6

6.9

183

1178

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

5.8

6.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

6.9

293

2079

R15

ICD-10 Finland

Faecal incontinence

1.7

6.9

133

785

37103

ICD-8 Finland

Corneal opacity, Keratoconus

13.7

6.9

H47.3

ICD-10 Finland

Other disorders of optic disc

3.1

6.9

108

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.6

6.8

173

1098

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

2.6

6.8

177

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.7

6.8

138

825

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

6.8

281

1980

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

6.8

1289

11062

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.1

6.8

338

JDB00

NOMESCO Finland

Gastrostomy

4.8

6.8

S01

ICPC

Pain/tenderness of skin

1.4

6.8

282

1991

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

6.8

144

872

R32

ICD-10 Finland

Unspecified urinary incontinence

1.6

6.8

154

950

F60.9

ICD-10 Finland

Personality disorder, unspecified

1.8

6.8

112

629

H61.2

ICD-10 Finland

Impacted cerumen

1.4

6.8

326

2365

N89

ICPC

Migraine

1.4

6.8

297

2118

N88

ICPC

Epilepsy

2.4

6.7

208

37602

ICD-8 Finland

Detachment of retina, Foramen, ruptura retinae

16.6

6.7

G40.89

ICD-10 Finland

Other epilepsy

2.8

6.7

143

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.7

1045

8815

L04AA27

ATC

fingolimod; oral

3.6

6.7

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

1.5

6.7

219

1476

U13

ICPC

Bladder symptom/complaint other

1.6

6.7

171

1087

EBA10

NOMESCO Finland

Surgical removal of tooth

1.2

6.7

1134

9639

A10AE04

ATC

insulin glargine; parenteral

1.3

6.7

539

4228

Z99.2

ICD-10 Finland

Dependence on renal dialysis

4.2

6.7

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

1.7

6.7

124

723

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

7.1

6.7

N05AF03

ATC

chlorprothixene; systemic

1.5

6.7

182

1177

R07.0

ICD-10 Finland

Pain in throat

1.3

6.7

478

3690

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

6.7

442

3372

J01AA07

ATC

tetracycline; systemic

1.2

6.6

1222

10464

Q21.10

ICD-10 Finland

Persistent ostium secundum

2.3

6.6

249

N04BB01

ATC

amantadine; oral

1.9

6.6

490

H04AA01

ATC

glucagon; nasal, parenteral

1.5

6.6

206

1371

W19

ICD-10 Finland

Unspecified fall

1.3

6.6

621

4962

M01AH05

ATC

etoricoxib; oral

1.1

6.6

4865

45656

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.1

6.6

336

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.7

6.6

129

765

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

2.5

6.6

203

H35.1

ICD-10 Finland

Retinopathy of prematurity

6.4

6.6

N06AA06

ATC

trimipramine; systemic

1.6

6.6

144

879

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.7

6.6

132

786

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

6.6

3479

32063

Q99.8

ICD-10 Finland

Other specified chromosome abnormalities

5.1

6.6

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

6.6

557

4396

L20.0

ICD-10 Finland

Besnier prurigo

1.3

6.6

649

5216

H10

ICD-10 Finland

Conjunctivitis

1.3

6.6

470

3627

S01XA18

ATC

ciclosporin; ophthalmic

2.7

6.6

152

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.1

6.6

5291

49891

RS110

NOMESCO Finland

3.2

6.5

101

N30.0

ICD-10 Finland

Acute cystitis

1.2

6.5

984

8273

R52.0

ICD-10 Finland

Acute pain

1.5

6.5

211

1418

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.5

6.5

196

1297

D02AE01

ATC

carbamide; topical

1.3

6.5

449

3445

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

6.5

414

3141

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

3.8

6.5

Congenital heart failure surgery

3.7

6.5

J47

ICD-10 Finland

Bronchiectasis

1.9

6.5

458

CGD40

NOMESCO Finland

Implantation of intracorneal ring segments

10.0

6.5

NG1DA

NOMESCO Finland

X-ray of knees

1.8

6.5

108

610

M01AC06

ATC

meloxicam; systemic, rectal

1.1

6.5

2595

23521

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.7

6.5

133

800

F34.1

ICD-10 Finland

Dysthymia

1.4

6.5

257

1802

R04.0

ICD-10 Finland

Epistaxis

1.3

6.5

365

2720

N02CC06

ATC

eletriptan; oral

1.4

6.5

271

1919

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

6.5

979

8235

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

6.5

234

1612

B01AA03

ATC

warfarin; systemic

1.2

6.5

895

7462

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.2

6.5

278

EB1WA

NOMESCO Finland

2.4

6.5

208

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.1

6.5

2934

26796

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

6.4

956

8030

H60

ICD-10 Finland

Otitis externa

1.4

6.4

316

2303

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

6.4

306

2218

CJA10

NOMESCO Finland

Implantation of phakic lens in posterior chamber

69.6

6.4

CGD00

NOMESCO Finland

Keratotomy for error of refraction

69.6

6.4

3602A

ICD-9 Finland

Disorders of the globe, Degenerative disorders of globe[MYOPIA MALIGNA]

69.6

6.4

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.7

6.4

134

811

Q10.0

ICD-10 Finland

Congenital ptosis

5.7

6.4

G40

ICD-10 Finland

Epilepsy

2.2

6.4

280

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

1.8

6.4

540

164

Kela drug reimbursment

Fingolimod

3.0

6.4

114

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.3

6.4

395

2984

R05FB02

ATC

cough suppressants and expectorants

1.1

6.4

2655

24115

Q93.5

ICD-10 Finland

Other deletions of part of a chromosome

14.2

6.4

B02AA02

ATC

tranexamic acid; systemic

1.2

6.4

1080

9180

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.3

6.4

623

5002

R03BA08

ATC

ciclesonide; inhalant

1.3

6.4

543

4288

H53

ICD-10 Finland

Visual disturbances

2.3

6.4

241

L60.0

ICD-10 Finland

Ingrowing nail

1.4

6.4

293

2112

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

6.4

324

2373

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.3

6.3

364

2718

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.5

6.3

186

1223

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

2.5

6.3

185

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

6.3

490

3820

F80.1

ICD-10 Finland

Expressive language disorder

2.0

6.3

378

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

3.0

6.3

115

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

1.9

6.3

447

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.5

6.3

214

1452

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

6.3

167

1073

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.7

6.3

131

790

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.4

6.3

322

2362

H91.1

ICD-10 Finland

Presbycusis

1.5

6.3

205

1379

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.6

6.3

154

969

R03AK08

ATC

formoterol and beclometasone; inhalant

1.5

6.3

227

1562

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

5.1

6.3

H50.50

ICD-10 Finland

Alternating hyperphoria

11.0

6.3

R3120

NOMESCO Finland

Training in mobility skills

5.9

6.3

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

2.0

6.3

345

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

6.3

122

723

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

2.5

6.3

187

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.4

6.3

290

2092

K07

ICPC

Swollen ankles/oedema

1.5

6.2

185

1221

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

6.2

108

620

37008

ICD-8 Finland

Refractive errors, Alia definita

+∞

6.2

LINSS

NOMESCO Finland

+∞

6.2

37603

ICD-8 Finland

Detachment of retina, Retinoschisis

+∞

6.2

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

2.9

6.2

125

N06AX17

ATC

milnacipran; oral

2.0

6.2

386

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.1

6.2

2155

19347

CKD20

NOMESCO Finland

Removal of vitreous body substitute

3.0

6.2

111

G43

ICD-10 Finland

Migraine

1.3

6.2

393

2985

D07AA02

ATC

hydrocortisone; topical

1.2

6.2

1163

9977

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

4.3

6.2

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.4

6.2

200

N05CD08

ATC

midazolam; nasal, systemic

1.7

6.2

128

773

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

2.2

6.2

250

D01AC03

ATC

econazole; topical

1.4

6.2

336

2493

C10AA05

ATC

atorvastatin; oral

1.1

6.2

2130

19122

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

1.8

6.2

519

R96

ICPC

Asthma

1.3

6.1

571

4561

R00.2

ICD-10 Finland

Palpitations

1.3

6.1

484

3785

D11

ICPC

Diarrhoea

1.2

6.1

923

7762

J01MA14

ATC

moxifloxacin; systemic

1.3

6.1

515

4060

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.4

6.1

235

1637

F17

ICPC

Glasses symptom/complaint

3.6

6.1

L12

ICPC

Hand/finger symptom/complaint

1.2

6.1

1118

9566

P05.1

ICD-10 Finland

Small for gestational age

3.7

6.1

G41.9

ICD-10 Finland

Status epilepticus, unspecified

2.7

6.1

141

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

5.3

6.1

D09

ICPC

Nausea

1.3

6.1

398

3032

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

6.1

246

1729

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

2.2

6.1

253

EMB30

NOMESCO Finland

Adenotomy

1.3

6.1

343

2557

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.3

6.1

348

2598

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.5

6.1

174

1140

R44

ICPC

Respiratory, Preventive immunization/medic

2.0

6.1

384

N06AB08

ATC

fluvoxamine; oral

1.5

6.1

163

1053

M54

ICD-10 Finland

Dorsalgia

1.2

6.1

802

6657

L86

ICPC

Back syndrome with radiating pain

1.4

6.1

333

2470

N06AG02

ATC

moclobemide; oral

1.4

6.1

261

1859

E16.19

ICD-10 Finland

Other specified hypoglycaemia

2.9

6.1

113

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.5

6.0

199

1344

S22.3

ICD-10 Finland

Fracture of rib

1.3

6.0

342

2551

H57.0

ICD-10 Finland

Anomalies of pupillary function

2.6

6.0

153

RS222

NOMESCO Finland

1.9

6.0

428

H01.0

ICD-10 Finland

Blepharitis

1.3

6.0

372

2813

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.6

6.0

161

1040

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

6.0

927

7810

HAHOM

NOMESCO Finland

1.8

6.0

100

565

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

6.0

913

7685

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

6.0

307

2254

H13

ICPC

Plugged feeling ear

1.2

6.0

1068

9116

H92.0

ICD-10 Finland

Otalgia

1.3

6.0

382

2901

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5209

41419

1.43

78.24

2.7

2.3

75.3

2224.4

nmol/l

0.50

4777

38146

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5556

45049

1.41

72.92

7.9

6.6

1.2

mmol/l

0.62

4612

38341

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5062

40802

1.39

66.80

7.4

6.1

1.2

mmol/l

0.90

4582

37264

(3018418) pH of Serum or Plasma

3463

26163

1.44

66.11

4.4

3.9

7.4

0.26

684

5059

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8445

74481

1.38

61.48

7.7

7.1

77.0

77.7

u/l

0.67

7980

70306

(3013707) Erythrocyte sedimentation rate by Westergren method

8471

74772

1.38

61.19

4.5

3.9

10.3

10.6

mm/h

0.77

7875

69832

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9177

82176

1.40

60.22

4.6

3.9

14.6

pmol/l

0.03

8389

75626

(3013115) Eosinophils [#/volume] in Blood

6362

53779

1.36

59.88

7.5

6.3

0.2

e9/l

0.13

5691

47563

(3006315) Basophils [#/volume] in Blood

6175

51962

1.36

59.84

7.2

6.1

0.0

e9/l

0.33

5471

45198

(3001604) Monocytes [#/volume] in Blood

6152

51773

1.36

59.41

7.2

6.0

0.6

e9/l

1.62

5452

45065

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10465

96043

1.48

59.40

5.3

4.6

2.2

2.1

mu/l

0.18

9741

89664

(3024561) Albumin [Mass/volume] in Serum or Plasma

4806

39171

1.36

56.04

5.3

4.9

36.4

36.3

g/l

0.63

4410

36551

(3037467) Urinalysis macro (dipstick) panel - Urine

7971

70120

1.35

55.83

4.9

4.0

—

(3019198) Lymphocytes [#/volume] in Blood

6316

53728

1.34

55.01

7.1

6.0

1.9

2.0

e9/l

1.59

5671

47715

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3378

26135

1.39

54.10

2.3

2.1

231.4

204.8

u/l

0.46

3166

24652

(3013650) Neutrophils [#/volume] in Blood by Automated count

6892

59535

1.33

53.29

10.1

9.0

3.9

4.0

e9/l

1.50

6136

52078

(42870588) Differential panel, method unspecified - Blood

4287

34663

1.35

51.40

7.1

6.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1459

9718

1.56

50.32

2.3

2.2

363.9

374.2

nmol/l

1.18

1348

8971

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4374

35674

1.34

48.80

1.9

98.5

97.3

pmol/l

0.86

2302

18978

(3044889) 12 lead EKG panel

7464

65783

1.31

47.18

3.7

3.2

—

(3022096) Basophils/100 leukocytes in Blood

5561

47200

1.31

45.80

7.4

6.3

0.7

0.44

5244

44269

(3023103) Potassium [Moles/volume] in Serum or Plasma

11049

103667

1.47

44.87

15.8

13.1

3.9

mmol/l

0.12

10775

100707

(3015377) Calcium [Moles/volume] in Serum or Plasma

3796

30606

1.34

44.86

3.4

3.3

2.4

mmol/l

0.64

3337

27109

(3013826) Glucose [Moles/volume] in Serum or Plasma

6471

56167

1.30

44.61

5.5

4.6

6.5

mmol/l

0.99

5985

51660

(3019550) Sodium [Moles/volume] in Serum or Plasma

11017

103363

1.46

44.21

15.7

13.0

139.6

mmol/l

0.34

10764

100646

(3006504) Eosinophils/100 leukocytes in Blood

5708

48770

1.30

44.13

7.4

6.2

2.9

2.8

0.52

5376

45716

(3015736) pH of Urine

4670

38875

1.31

43.70

3.6

3.1

—

5.9

—

(3019069) Monocytes/100 leukocytes in Blood

5730

49051

1.30

43.39

7.6

6.4

8.5

8.3

1.92

5418

46241

(3035350) Ketones [Presence] in Urine by Test strip

5828

50185

1.29

41.43

3.9

3.3

0.0

estimate

1.54

1190

9494

(3002030) Lymphocytes/100 leukocytes in Blood

5905

50950

1.29

41.26

7.3

6.2

29.5

0.13

5577

47851

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3029

23862

1.35

41.15

2.3

2.8

mg/l

0.26

2554

20607

(3018010) Neutrophils/100 leukocytes in Blood

5825

50203

1.29

40.94

7.1

6.0

56.0

56.1

0.28

5503

47324

(3031040) Bacteria [#/volume] in Urine by Automated count

7490

66684

1.29

40.58

5.0

4.0

2995.7

1477.7

e6/l

0.57

821

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5658

48674

1.28

39.98

6.0

11.0

11.1

umol/l

0.16

5340

45924

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11555

109800

1.52

39.92

15.7

13.3

73.1

72.6

umol/l

1.06

11550

109754

(3009261) Glucose [Presence] in Urine by Test strip

5858

50772

1.28

38.39

4.0

3.4

0.0

estimate

0.61

1191

9547

(3021601) Nitrite [Presence] in Urine by Test strip

5808

50375

1.27

37.49

5.3

4.5

0.0

estimate

0.26

1229

9789

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1651

11955

1.43

36.92

7.8

6.3

1.1

mmol/l

0.61

1524

11217

(3032080) INR in Blood by Coagulation assay

4098

34108

1.29

36.55

8.6

7.3

1.2

inr

0.18

1377

10477

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5675

49297

1.26

35.37

3.3

2.9

98.6

99.4

ug/l

0.08

5282

46344

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9547

88351

1.31

35.13

5.3

4.9

38.5

38.6

mmol/mol

0.62

8909

82907

(3021960) Folate [Moles/volume] in Serum or Plasma

2507

19622

1.34

34.64

1.6

1.5

20.5

20.4

nmol/l

0.18

2162

17071

(3019309) Folate [Moles/volume] in Red Blood Cells

1929

14529

1.38

34.09

1.9

1.7

1194.6

1165.7

nmol/l

0.72

1421

11221

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3298

26946

1.30

33.22

1.4

1.3

2.0

1.8

u/ml

0.25

870

7238

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1816

13615

1.38

32.90

2.3

2.5

29.4

29.7

1.51

1767

13218

(40760892) CBC W Ordered Manual Differential panel - Blood

2988

24167

1.30

32.34

5.1

4.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

145

490

2.97

32.23

1.1

1.5

9.0

nmol/l

1.32

(3021589) Normoblasts [#/volume] in Blood

5333

46313

1.25

32.20

10.9

9.0

0.0

e9/l

1.19

4421

37809

(3005719) IgG [Mass/volume] in Serum or Plasma

1149

7964

1.48

32.10

2.9

2.7

10.0

10.4

g/l

3.49

1041

7343

(3026782) Osmolality of Urine

2331

18240

1.33

31.92

3.2

2.7

538.2

550.3

mosm/kgh2o

1.68

1989

15520

(3037522) Nuclear Ab [Titer] in Serum

1946

14848

1.36

31.46

1.4

516.6

535.7

titre

0.16

384

2944

(40761511) CBC panel - Blood by Automated count

11560

110561

1.45

31.26

13.5

11.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3839

32194

1.27

30.93

3.5

3.1

122.1

67.2

ng/l

0.38

2208

18606

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3594

29924

1.27

30.67

2.8

2.6

56.8

57.1

u/l

0.06

3281

27728

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11558

110601

1.45

30.52

10.9

9.3

26.2

26.5

u/l

0.44

11182

107190

(1616796) Gas panel - Central venous blood

374

1969

1.92

30.18

4.4

3.5

—

(3018095) Leukocytes [#/volume] in Urine

4082

34578

1.26

29.97

4.2

3.5

62.7

84.6

e6/l

1.61

2854

23554

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11090

105458

1.37

29.62

14.5

12.0

20.8

21.8

mg/l

2.46

8738

81438

(3007164) IgA [Mass/volume] in Serum or Plasma

2884

23443

1.29

29.60

1.6

1.4

2.1

2.2

g/l

1.93

1759

14548

(3000850) Epithelial cells [#/volume] in Urine

2467

19723

1.31

28.58

3.1

2.5

6.7

6.5

e6/l

0.21

2175

17183

(3022948) Iron [Moles/volume] in Serum or Plasma

1873

14401

1.35

28.55

2.8

2.4

13.6

13.8

umol/l

0.42

1717

13458

(3002582) Erythrocytes [#/volume] in Urine

3429

28633

1.26

28.02

3.7

3.1

78.8

79.4

e6/l

0.01

2669

21636

(3030467) Casts [#/volume] in Urine by Automated count

3169

26218

1.27

27.97

3.6

3.0

0.3

0.4

e6/l

0.45

2422

19411

(3029937) Albumin [Presence] in Urine by Test strip

3221

26701

1.27

27.97

4.4

3.7

0.0

estimate

3.86

1184

9500

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1023

7123

1.47

27.79

4.7

3.7

1.2

mmol/l

0.41

846

6264

(3044290) Cell count panel - Cerebral spinal fluid

399

2203

1.83

27.77

1.7

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

456

2630

1.75

27.41

1.6

1.5

419.9

492.7

mg/l

4.74

429

2513

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

207

911

2.28

26.93

1.1

217.9

242.8

mg/l

1.31

173

808

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

211

938

2.26

26.80

1.2

32.6

39.8

mg/l

2.63

161

785

(3015171) Extractable nuclear Ab [Units/volume] in Serum

659

4224

1.58

26.35

1.3

1.2

1.7

1.0

u/ml

0.38

353

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2311

18494

1.30

26.30

1.7

1.6

32270515.1

34373443.0

pmol/l

0.05

1881

15742

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10179

95977

1.28

26.28

4.2

3.9

5.7

5.8

mmol/l

1.19

9335

89052

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1868

14520

1.33

26.24

4.7

3.9

0.8

mmol/l

0.61

1709

13642

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

413

2349

1.78

26.06

1.7

1.6

20.8

22.8

e6/l

0.13

318

1790

(36304419) Bacteria [Presence] in Urine

3121

25957

1.26

26.01

3.6

2.9

—

(3002385) Erythrocyte distribution width [Ratio]

9662

90566

1.26

25.98

17.7

14.5

13.5

0.59

9495

88730

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

934

6474

1.47

25.92

4.9

4.1

81.7

83.5

ng/l

0.21

803

5736

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

411

2340

1.77

25.84

1.5

3.6

3.7

mmol/l

1.44

379

2211

(3007853) Bacteria identified in Skin by Aerobe culture

1552

11760

1.36

25.83

1.9

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1711

13168

1.34

25.69

2.8

2.4

g/l

0.48

1565

12281

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

412

2352

1.77

25.67

1.7

11044.1

1165.6

e6/l

0.56

334

1886

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1962

15402

1.32

25.66

2.8

2.9

2.4

mmol/l

0.13

1696

13450

(4027681)

177

746

2.38

25.46

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1210

8834

1.40

25.27

3.6

3.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2711

22271

1.27

24.88

2.0

1.9

1.0

1.1

mg/l

0.99

1969

16557

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3956

33931

1.23

24.75

3.6

3.2

30.3

33.1

u/l

1.88

3753

32273

(40761536) Microorganisms panel - Urine sediment

1215

8909

1.40

24.72

4.8

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4485

39040

1.22

24.19

4.1

3.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

495

3021

1.66

24.18

9.9

6.4

1.4

1.3

mg/l

1.12

466

2852

(3027315) Oxygen [Partial pressure] in Blood

364

2048

1.79

23.85

4.7

4.0

8.7

8.8

kpa

0.57

356

2014

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2971

24783

1.25

23.75

1.7

1.6

1.3

1.4

mmol/l

1.62

2497

21293

(3012501) Base excess in Blood by calculation

361

2032

1.79

23.62

4.8

4.0

2.3

mmol/l

0.19

252

1343

(3013290) Carbon dioxide [Partial pressure] in Blood

361

2033

1.79

23.58

4.8

4.0

5.1

5.0

kpa

0.65

353

2000

(3035941) MCH [Entitic mass]

12236

119067

1.61

23.41

21.3

17.5

30.1

0.01

12096

117679

(3024731) MCV [Entitic volume]

12236

119074

1.61

23.32

21.3

17.5

90.2

0.08

12096

117682

(3010813) Leukocytes [#/volume] in Blood

12240

119127

1.61

23.26

21.5

17.6

6.6

6.7

e9/l

3.94

11968

116000

(3007461) Platelets [#/volume] in Blood

12226

118965

1.60

23.17

21.4

17.6

257.5

258.5

e9/l

0.90

11976

116119

(3000963) Hemoglobin [Mass/volume] in Blood

12240

119141

1.61

23.07

21.5

17.6

135.4

135.8

g/l

2.00

12102

117757

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1574

12144

1.33

23.05

2.9

2.5

23.2

23.4

0.25

1317

10547

(3026361) Erythrocytes [#/volume] in Blood

12236

119094

1.61

23.05

21.4

17.5

4.5

e12/l

1.27

11964

116002

(3013005) Retinol [Moles/volume] in Serum or Plasma

148

607

2.45

22.66

2.5

2.4

2.0

1.8

umol/l

0.90

140

579

(3011397) Hemoglobin [Presence] in Urine by Test strip

2793

23252

1.25

22.53

3.7

3.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

978

7020

1.42

22.43

3.3

4.5

4.6

pmol/l

0.50

872

6303

(3033658) Prothrombin time (PT) actual/Normal

2936

24612

1.24

22.22

4.4

4.1

93.3

92.7

0.69

2846

23979

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

907

6434

1.44

22.21

10.8

8.5

24.8

24.7

mmol/l

0.57

900

6400

(3028626) Oxygen [Partial pressure] in Capillary blood

486

3018

1.63

22.18

8.4

5.2

9.1

9.0

kpa

0.55

460

2835

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

189

873

2.17

21.95

1.1

—

(40768797) Stomach Pathology biopsy report

1635

12776

1.32

21.81

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

622

4109

1.53

21.75

2.1

2.0

39.6

39.7

u/l

0.05

562

3721

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

233

1170

2.00

21.68

3.1

2.7

22.7

21.5

nmol/l

0.65

222

1121

(3010421) pH of Blood

397

2355

1.70

21.62

4.8

3.9

7.4

0.17

355

2000

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1762

13929

1.30

21.57

1.8

—

(3026008) Bacteria identified in Urine by Culture

3289

28016

1.23

21.26

3.4

2.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

10578

100820

1.27

21.12

15.8

12.8

39.9

40.1

0.97

7911

79507

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1245

9412

1.35

20.80

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

998

7288

1.40

20.69

2.3

21.8

23.5

au/ml

0.14

501

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7798

72136

1.20

20.64

3.4

3.0

40.2

41.8

u/l

1.08

7312

68293

(3023368) Bacteria identified in Blood by Culture

2727

22831

1.24

20.63

4.4

4.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1233

9337

1.35

20.36

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

1862

14980

1.28

19.75

2.4

2.6

110.5

123.7

ug/g

0.94

1479

11798

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2495

20777

1.24

19.69

3.0

967.2

1123.7

ng/l

1.42

2033

17462

(3005322) IgE [Units/volume] in Serum or Plasma

1028

7621

1.37

19.42

1.4

1.3

204.6

236.5

u/ml

0.55

942

7079

(3009508) Creatinine [Moles/volume] in Urine

3288

28217

1.22

19.40

3.6

3.2

7.7

7.9

mmol/l

1.42

2816

24249

(3017446) Testosterone [Moles/volume] in Serum or Plasma

973

7155

1.38

19.32

2.2

2.1

11.8

11.9

nmol/l

0.06

845

6349

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10507

100295

1.25

19.24

4.7

4.2

2.8

mmol/l

4.18

9735

93891

(3009466) Valproate [Moles/volume] in Serum or Plasma

264

1440

1.84

19.23

5.7

5.3

407.2

369.2

umol/l

4.02

234

1267

(3020630) Protein [Mass/volume] in Serum or Plasma

877

6343

1.41

19.21

2.5

66.8

66.7

g/l

0.06

808

5853

(40767503) Oxygen content in Capillary blood by calculation

322

1865

1.74

19.16

2.9

2.4

17.0

16.7

0.44

186

918

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10396

99131

1.24

19.14

4.3

3.9

4.7

mmol/l

4.27

9655

93399

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

919

6709

1.39

19.06

1.3

39.3

47.1

au/ml

0.43

276

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

139

601

2.32

18.99

1.1

1.0

1.1

u/l

0.14

276

(3021901) Oxygen saturation in Capillary blood

273

1513

1.81

18.89

4.0

2.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2202

18178

1.25

18.68

1.3

26.5

30.8

iu/ml

0.77

659

5546

(3000494) Fungus identified in Specimen by Culture

1458

11483

1.30

18.15

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1201

9251

1.32

17.56

3.2

3.0

1.7

1.51

1053

8305

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9939

94546

1.22

17.51

12.5

10.8

88.2

ml/min/173m2

0.04

8127

76775

(3028026) IgM [Mass/volume] in Serum or Plasma

849

6203

1.39

17.50

2.0

1.8

1.4

1.3

g/l

0.44

779

5737

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9971

94921

1.21

17.22

3.8

3.5

1.3

mmol/l

0.87

9223

88755

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2006

16540

1.25

17.04

3.6

3.4

411.5

497.5

ng/l

0.30

1375

11217

(3023520) Reticulocytes [#/volume] in Blood

905

6713

1.37

17.00

3.1

2.8

69.4

70.2

e9/l

0.23

673

4926

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10303

98435

1.22

16.98

4.2

3.8

1.5

mmol/l

0.60

9562

92414

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1105

8473

1.33

16.65

6.5

4.8

5.9

5.8

kpa

0.13

1075

8219

(3041096) Erythrocytes [Presence] in Urine by Automated

3269

28384

1.20

16.54

3.7

2.9

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.76

16.53

7.7

7.5

—

(3018133) Calcium [Moles/volume] in Urine

279

2.83

16.44

2.4

3.0

2.7

2.6

mmol/l

0.20

253

(3015235) Bicarbonate [Moles/volume] in Capillary blood

352

2180

1.63

16.32

5.3

3.4

24.1

24.5

mmol/l

0.86

320

1906

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

199

1048

1.91

16.24

1.1

1.0

—

(3002032) Base excess in Venous blood by calculation

1098

8448

1.32

16.15

6.6

4.8

1.8

mmol/l

0.14

898

6830

(3012544) pH of Venous blood

1129

8723

1.32

16.11

6.5

4.8

7.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

488

3279

1.50

15.80

1.9

1.8

0.2

g/l

0.18

455

3124

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

213

1160

1.84

15.68

1.1

—

11.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

128

581

2.21

15.67

3.2

2.7

11.8

12.5

0.25

120

555

(3022145) Colonoscopy Study observation

1347

10696

1.28

15.63

1.3

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1605

13034

1.26

15.47

2.1

2.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

686

4941

1.40

15.39

1.1

49.8

7.9

u/ml

—

(40758558) Short blood count panel - Blood

2986

25866

1.20

15.29

7.6

7.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

289

1741

1.67

14.98

4.7

3.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

935

7108

1.33

14.93

6.2

4.4

4.8

kpa

0.03

907

6882

(3020779) Urea [Moles/volume] in Serum or Plasma

1015

7822

1.32

14.73

11.2

8.2

8.1

8.5

mmol/l

1.23

981

7512

(4010399)

881

6657

1.34

14.66

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

108

470

2.30

14.65

3.1

2.7

266.3

266.5

e6/l

0.00

273

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

853

6418

1.35

14.60

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1106

8637

1.30

14.56

1.2

140.5

146.9

iu/ml

0.22

399

3301

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

177

932

1.90

14.51

2.8

2.3

12.5

12.1

0.15

111

529

(3002179) Metamyelocytes/100 leukocytes in Blood

969

7439

1.32

14.45

4.3

4.0

0.5

0.6

0.50

207

1560

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1903

15874

1.23

14.30

3.0

2.6

1.0

1.3

e6/l

0.74

1105

8753

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

169

882

1.92

14.24

2.9

2.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.37

14.13

6.3

4.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

840

6338

1.34

14.11

3.0

2.9

142.0

159.6

ng/l

0.83

766

5675

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

834

6290

1.34

14.05

6.8

4.5

5.1

kpa

0.14

781

5882

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2042

17187

1.22

14.02

1.3

6.8

11.1

u/ml

3.08

778

7009

(3026493) Urate [Moles/volume] in Serum or Plasma

2761

23907

1.19

14.02

2.8

2.5

3954.5

3478.3

umol/l

0.29

2411

21134

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

490

3377

1.46

14.01

1.9

1.8

1.2

g/l

0.20

461

3226

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

802

6026

1.35

13.85

6.9

4.5

1.5

1.4

mmol/l

0.12

585

4379

(3012516) Albumin [Mass/volume] in Urine

2733

23665

1.19

13.85

3.4

3.3

570.0

430.4

mg/l

0.62

1702

15095

(1175426) CD3 cells/100 lymphocytes in Blood

177

948

1.87

13.80

2.8

2.3

73.8

72.4

0.64

171

915

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

119

554

2.15

13.74

3.1

2.5

25.6

27.6

1.16

113

533

(3009343) pH of Capillary blood

823

6219

1.34

13.68

6.9

4.5

7.4

0.10

137

678

(3009445) Proteinase 3 Ab [Units/volume] in Serum

562

3993

1.42

13.65

1.6

25.0

9.6

u/ml

0.81

123

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.21

13.50

6.7

4.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

399

2667

1.51

13.31

1.4

282.1

283.9

ug/g

0.06

218

1479

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

415

2819

1.48

12.80

2.3

2.4

473.6

461.4

ug/l

0.03

376

2614

(3003327) Ova and parasites identified in Stool by Light microscopy

569

4098

1.40

12.80

1.8

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

591

4286

1.39

12.76

1.6

1.5

9.9

9.3

u/l

0.44

461

3427

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2435

21016

1.19

12.65

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2832

24775

1.18

12.54

4.3

4.0

10.0

10.4

mg/mmol

0.13

1768

15969

(3011412) CD3 cells [#/volume] in Blood

200

1146

1.75

12.53

3.0

2.6

1.4

1.2

e9/l

0.91

135

682

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1305

10604

1.25

12.39

5.7

5.9

—

(3017181) Myelocytes/100 leukocytes in Blood

1026

8104

1.28

12.35

4.6

4.3

0.8

0.9

0.12

268

2137

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

686

5126

1.35

12.30

6.8

5.4

24.0

24.1

mmol/l

0.40

634

4708

(3004588) Protein electrophoresis panel - Serum or Plasma

673

5020

1.35

12.21

2.1

2.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

471

3315

1.43

12.09

3.1

3.4

3.5

g/l

0.78

450

3153

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

490

3483

1.42

11.91

1.6

62.0

3.2

iu/ml

0.89

105

717

(3013139) Helicobacter pylori Ag [Presence] in Stool

878

6828

1.30

11.91

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

350

2333

1.51

11.87

1.3

46.1

44.9

u/ml

0.04

220

(3025159) Blasts/100 leukocytes in Blood

939

7377

1.29

11.78

4.8

4.3

0.2

0.06

213

1695

(3019150) Specific gravity of Urine by Refractometry

2523

21980

1.18

11.63

4.0

3.6

1.0

kg/l

0.31

393

3258

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

381

2602

1.47

11.48

2.2

2.1

10.2

10.7

mg/l

0.73

347

2445

(3000991) Gas panel - Venous blood

993

7885

1.28

11.45

10.7

8.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

977

7748

1.28

11.38

4.7

4.3

0.1

1.74

251

1987

(3036489) Thrombin time

551

4036

1.38

11.23

2.4

2.7

21.4

0.09

459

3489

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

169

960

1.76

10.97

1.8

1.5

—

(36660697) Celiac disease serology panel - Serum

1206

9853

1.24

10.87

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

158

883

1.79

10.85

3.1

2.7

494.7

530.3

e6/l

0.50

127

708

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

448

3189

1.41

10.83

1.7

1.6

231.4

312.2

titre

0.28

134

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

326

2187

1.50

10.76

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

322

2156

1.50

10.73

7.9

6.1

836.2

1607.9

iu/ml

0.36

279

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

155

865

1.79

10.70

3.2

2.8

0.2

e9/l

0.17

127

708

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

494

3584

1.39

10.69

2.7

3.3

93.1

93.2

0.05

452

3352

(3007930) Methemoglobin/Hemoglobin.total in Blood

443

3155

1.41

10.69

6.5

4.9

0.9

0.07

422

2935

(3023410) Appearance of Cerebral spinal fluid

195

1162

1.68

10.67

2.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1179

9635

1.24

10.60

4.5

4.4

239.2

240.3

u/l

0.08

1124

9154

(40768804) Tissue Pathology biopsy report

4424

40398

1.14

10.55

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

181

1062

1.71

10.50

1.8

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

420

2977

1.42

10.42

1.4

1.3

41.6

39.1

u/ml

0.06

187

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

445

3195

1.40

10.26

6.3

4.8

1.7

0.29

421

2966

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

208

1276

1.63

10.20

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

317

2141

1.49

10.15

1.8

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

454

3279

1.39

10.11

2.9

3.1

169.1

178.7

1.67

426

3121

(3014111) Lactate [Moles/volume] in Serum or Plasma

940

7543

1.26

9.93

8.4

7.8

1.3

mmol/l

0.05

894

7246

(3020961) Endomysium IgA Ab [Titer] in Serum

786

6177

1.29

9.85

1.1

1.2

241.0

234.5

titre

0.03

176

(3010375) cycloSPORINE [Mass/volume] in Blood

104

525

1.98

9.81

30.4

27.0

119.6

121.9

ug/l

0.11

438

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

207

2.61

9.77

9.3

6.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

228

1448

1.58

9.71

1.6

—

(3013512) EKG study

2743

24387

1.15

9.47

3.7

3.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

190

1162

1.64

9.47

1.4

1.3

0.4

g/l

0.01

144

813

(3027135) IgG subclass 1 [Mass/volume] in Serum

190

1162

1.64

9.47

1.4

1.3

6.4

6.6

g/l

0.53

142

818

(3028192) IgG subclass 2 [Mass/volume] in Serum

190

1162

1.64

9.47

1.4

1.3

3.1

2.8

g/l

1.19

141

818

(3006184) Hemoglobin [Mass/volume] in Capillary blood

295

1993

1.49

9.47

2.5

2.2

131.6

131.4

g/l

0.04

235

1454

(4062490)

189

1157

1.64

9.39

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

242

1571

1.54

9.38

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

378

2682

1.42

9.36

1.4

1.3

5.3

8.9

u/ml

0.58

256

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1109

9126

1.23

9.33

8.6

7.5

5.1

kpa

0.01

1067

8708

(3002173) Hemoglobin [Mass/volume] in Arterial blood

930

7511

1.25

9.29

9.4

8.3

123.1

122.2

g/l

0.63

901

7217

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

382

2723

1.41

9.22

1.4

1.3

9.6

10.3

u/ml

0.07

418

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

225

1443

1.56

9.21

1.6

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1107

9122

1.23

9.20

8.6

7.5

12.9

13.0

kpa

0.18

1065

8698

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

902

7271

1.25

9.17

2.4

2.3

6684.2

6151.7

u/l

0.15

291

2868

(3016018) Differential panel - Cerebral spinal fluid

195

1211

1.61

9.15

1.8

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

254

1676

1.52

9.15

6.8

3.5

1338.7

677.2

u/ml

0.29

(3047181) Lactate [Moles/volume] in Blood

377

2686

1.41

9.13

7.2

5.3

1.2

1.3

mmol/l

0.47

343

2349

(3014576) Chloride [Moles/volume] in Serum or Plasma

1249

10428

1.21

9.11

7.9

7.4

104.9

104.6

mmol/l

1.35

1226

10217

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

445

3265

1.37

9.05

2.0

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

334

2.18

8.97

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

380

2723

1.40

8.92

2.0

1.9

4.0

7.1

iu/l

0.53

130

1065

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

266

1783

1.50

8.90

1.7

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

139

797

1.75

8.84

2.6

2.9

98.5

96.6

0.29

127

741

(21494815) CD4 cells/100 lymphocytes in Specimen

170

1030

1.65

8.82

2.8

2.5

48.3

42.4

0.79

120

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1337

11270

1.20

8.82

3.4

3.0

6.5

7.5

umol/l

1.41

1122

9671

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

164

985

1.67

8.80

2.1

33.0

32.6

0.74

164

977

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2378

21036

1.15

8.72

4.6

4.4

2.2

2.8

ug/l

1.15

2123

19096

(3026250) Tacrolimus [Mass/volume] in Blood

100

520

1.92

8.71

42.7

37.7

6.9

7.3

ug/l

1.29

486

(3016244) Insulin [Units/volume] in Serum or Plasma

168

1019

1.65

8.69

3.1

3.5

27.2

26.1

mu/l

0.13

158

960

(3003396) Base excess in Arterial blood by calculation

1100

9117

1.22

8.63

8.7

7.6

0.9

mmol/l

0.08

872

7072

(1002224) Polysomnography panel

599

4625

1.30

8.63

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

232

1522

1.53

8.61

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

870

7037

1.25

8.59

1.5

1.4

23.8

25.9

iu/l

1.15

714

5982

(3023420) DNA double strand Ab [Units/volume] in Serum

189

1185

1.60

8.56

1.7

1.6

25.0

32.6

iu/ml

0.62

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1732

14974

1.18

8.54

3.2

2.8

3.7

3.2

e6/l

0.87

938

7884

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

282

1930

1.47

8.52

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

282

1931

1.46

8.50

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

137

792

1.73

8.48

1.4

1.3

2.0

1.9

mmol/l

0.26

126

745

(3017143) Hepatitis C virus Ab [Presence] in Serum

1770

15346

1.17

8.42

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

578

4463

1.30

8.33

11.3

10.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

128

2.88

8.18

7.1

6.0

2.7

2.3

mg/l

0.50

109

(3049233) Organic acids panel - Urine

4.51

8.06

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

278

2.23

8.04

1.0

1.1

—

(3016502) Oxygen saturation in Arterial blood

979

8084

1.22

7.98

9.1

8.1

95.5

95.9

0.63

951

7757

(3008152) Bicarbonate [Moles/volume] in Arterial blood

624

4897

1.28

7.96

7.7

6.7

24.7

24.5

mmol/l

0.63

584

4536

(3019060) Gas panel - Arterial blood

641

5051

1.28

7.91

5.6

4.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

422

3139

1.35

7.91

1.7

39.6

41.1

nmol/l

0.55

415

3065

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

142

2.74

7.87

4.8

3.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

698

5564

1.26

7.84

1.7

1.6

326.3

311.4

mu/l

0.44

617

5017

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

490

1.90

7.84

2.7

2.5

63.0

52.7

umol/l

2.25

427

(3023419) Bacteria identified in Sputum by Culture

156

957

1.63

7.77

2.7

2.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

2646

1.38

7.75

2.0

2.2

10.2

g/l

0.07

302

2241

(3039000) Anion gap in Blood

264

1820

1.45

7.73

8.5

6.4

10.9

11.3

mmol/l

1.17

249

1619

(3052851) Hemolysis interference index of Serum or Plasma

388

2860

1.36

7.72

3.1

3.0

—

(3018572) Chloride [Moles/volume] in Blood

264

1821

1.45

7.71

8.5

6.4

104.8

105.2

mmol/l

0.63

249

1620

(42529406) Shigella sp [Presence] in Stool by Culture

414

3092

1.34

7.58

1.2

—

(3000492) Spirometry study

1220

10350

1.19

7.49

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.21

7.45

2.0

2.9

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

530

1.83

7.33

1.4

1.2

74.8

71.3

0.16

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

589

1.78

7.28

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

406

3048

1.34

7.20

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

449

1.89

7.15

1.1

1.2

112.8

106.9

0.56

404

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

137

834

1.64

7.08

2.9

2.7

1021.1

767.9

e6/l

0.93

310

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

1.8

1.9

mg/l

0.10

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

1.0

1.3

mg/l

0.29

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

2.2

2.7

mg/l

0.20

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

2.5

3.6

mg/l

0.73

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

3.2

4.1

mg/l

0.41

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

0.8

1.3

mg/l

0.80

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

1.0

2.1

mg/l

1.24

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

128

2.73

7.04

1.8

1.7

2.7

mg/l

0.75

(3014765) Yersinia sp identified in Stool by Organism specific culture

408

3076

1.33

7.04

1.2

—

(3022313) Gas panel - Capillary blood

589

4670

1.27

6.95

7.5

4.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1087

9190

1.19

6.94

2.5

34.1

44.2

u/l

1.00

925

7881

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

289

2069

1.40

6.92

1.7

1.9

187.5

188.9

pmol/l

0.08

284

1974

(3004119) Hemoglobin [Mass/volume] in Venous blood

615

4907

1.26

6.89

5.4

4.0

129.8

130.5

g/l

0.35

599

4790

(40768443) Skin Pathology biopsy report

529

4145

1.28

6.88

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

427

1.90

6.87

1.1

1.2

93.3

92.5

0.07

196

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

245

2.20

6.87

1.4

1.3

114.5

112.3

nmol/l

0.05

182

(3025941) Bacteria identified in Stool by Culture

775

6347

1.23

6.86

1.3

1.2

—

(3004451) EKG impression Narrative

358

1.98

6.86

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

438

1.87

6.69

1.1

93.2

92.5

0.09

195

(3033923) Metanephrine [Moles/time] in 24 hour Urine

168

2.44

6.59

1.1

0.6

0.7

umol/24h

1.13

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

133

2.63

6.56

1.8

1.7

0.8

2.2

mg/l

2.59

(3027273) Bicarbonate [Moles/volume] in Venous blood

476

3709

1.29

6.48

5.4

3.6

25.2

mmol/l

0.03

463

3584

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2970

27118

1.12

6.41

1.7

—

(3012565) Volume of 24 hour Urine

452

1.83

6.40

2.2

1853.6

2061.6

1.14

409

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

298

2175

1.37

6.39

1.4

1.3

4.8

3.5

u/ml

0.15

157

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

239

1680

1.43

6.38

1.3

1.2

133.3

137.0

titre

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

141

2.55

6.37

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

347

2595

1.34

6.36

1.9

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

518

1.77

6.36

1.5

1.7

2.3

8.7

nmol/l

0.74

423

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

2846

1.33

6.35

2.0

2.1

3.7

3.8

g/l

0.42

278

2053

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

125

766

1.63

6.34

12.1

13.1

829.6

818.9

nmol/l

0.09

118

738

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

2847

1.33

6.34

2.0

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

261

1867

1.40

6.32

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

253

1802

1.41

6.28

1.3

1.6

0.6

0.7

g/l

3.54

185

1382

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

128

792

1.62

6.25

18.3

18.7

1518.7

2602.2

nmol/l

0.44

121

767

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2700

1.33

6.21

2.0

2.2

3.0

3.1

g/l

0.67

287

2116

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

120

2.66

6.17

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

200

1369

1.46

6.17

1.3

78.7

54.5

u/ml

0.56

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

338

1.95

6.14

2.1

1.7

0.2

nmol/l

0.54

248

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

2852

1.32

6.14

2.0

2.1

7.2

7.4

g/l

0.63

289

2160

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

447

3482

1.29

6.13

1.1

10.2

6.3

u/ml

0.41

489

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.94

6.12

1.4

1.2

1.3

1.2

u/field

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

107

637

1.68

6.09

1.6

1.5

—

(3016038) Potassium [Moles/volume] in Urine

557

1.72

6.00

2.7

1.6

34.0

35.1

mmol/l

0.15

498

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

870

7307

1.20

5.99

2.5

70.3

71.7

ml/min/173m2

0.47

382

2764

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1029

8773

1.18

5.98

2.6

2.5

0.2

g/l

0.69

964

8203

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5092

47930

1.10

5.95

4.0

3.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

149

968

1.54

5.93

1.3

5.4

5.5

umol/l

0.05

143

887

(3020717) Zinc [Moles/volume] in Serum or Plasma

108

650

1.66

5.91

2.0

1.6

20.8

23.8

umol/l

0.57

102

622

(3029634) Reagin Ab [Titer] in Serum by VDRL

253

1827

1.39

5.83

1.9

3.9

7.7

titre

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

313

2341

1.34

5.78

1.4

1.5

0.4

nmol/l

0.40

253

1862

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

340

2577

1.32

5.73

1.5

1.4

9.2

10.9

iu/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1874

16750

1.13

5.73

4.1

3.8

21.7

21.6

0.06

793

7333

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

319

2396

1.33

5.73

1.9

1.5

127.8

112.0

u/ml

0.51

444

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

581

1.69

5.69

2.6

43.3

40.8

0.56

192

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

128

812

1.58

5.68

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

147

963

1.53

5.66

1.8

1.6

283.7

282.0

mosm/kgh2o

0.48

111

752

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

567

1.69

5.66

1.2

1.1

—

(44790047)

168

1133

1.48

5.63

1.8

1.6

—

(44790049)

168

1133

1.48

5.63

1.8

1.6

—

(44806118)

168

1134

1.48

5.61

1.8

1.6

—

(44790048)

168

1134

1.48

5.61

1.8

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.23

5.52

1.7

2.1

—

(3011985) Renin [Units/volume] in Plasma

193

1343

1.44

5.51

1.7

1.6

61.9

71.5

mu/l

0.39

167

1216

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

174

1188

1.47

5.49

1.5

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

271

2001

1.36

5.47

2.2

2.1

0.0

g/l

0.79

247

1839

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

181

1247

1.45

5.46

1.4

342.8

347.6

pmol/l

0.04

137

984

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

578

4708

1.23

5.45

2.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

336

2562

1.31

5.45

1.8

1.5

40.3

20.1

u/ml

—

(40761535) Cells panel - Urine sediment

845

7144

1.19

5.43

3.9

3.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

210

2.14

5.42

1.6

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

191

2.19

5.39

1.9

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

331

2524

1.31

5.37

2.8

2.6

—

(3051651) Icteric interference index of Serum or Plasma

104

637

1.63

5.36

3.9

3.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

267

1975

1.35

5.34

2.2

2.1

0.0

g/l

0.00

246

1835

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

286

2138

1.34

5.33

1.3

1.2

23.8

19.9

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

180

1246

1.45

5.31

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

571

1.66

5.27

1.8

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

289

2172

1.33

5.21

2.2

2.1

0.0

g/l

0.09

264

2004

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

336

2581

1.30

5.18

1.9

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

352

1.84

5.18

1.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

158

1072

1.47

5.18

1.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

417

3295

1.27

5.16

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

208

2.11

5.15

2.2

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

124

801

1.55

5.13

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

765

6454

1.19

5.06

2.1

2.2

7.9

7.5

ug/l

0.15

666

5650

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

316

2421

1.31

4.99

2.2

0.8

g/l

0.05

276

2117

(3026389) Candida sp identified in Specimen by Organism specific culture

220

1597

1.38

4.98

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

250

1854

1.35

4.95

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

291

2207

1.32

4.94

2.1

2.0

38.6

38.1

g/l

0.66

259

1923

(3023511) Choriogonadotropin [Units/volume] in Urine

477

3850

1.24

4.93

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

419

3338

1.26

4.87

4.5

3.7

0.3

0.4

g/l

0.31

209

1570

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

213

2.06

4.86

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8446

81677

1.09

4.85

3.5

3.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

152

1038

1.46

4.85

1.5

1.6

51.8

54.4

0.31

651

(3051611) Lipemic interference index of Serum or Plasma

143

965

1.48

4.84

3.9

3.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

181

1278

1.42

4.83

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

104

655

1.59

4.83

1.8

1.5

10.4

6.6

ug/l

0.57

586

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

617

1.60

4.80

1.9

1.8

129.4

133.2

0.26

581

(40759836) Histone Ab [Presence] in Serum by Immunoblot

131

870

1.51

4.80

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

550

4522

1.22

4.79

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

131

871

1.50

4.77

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

123

808

1.52

4.75

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

131

873

1.50

4.73

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

243

1809

1.34

4.71

1.2

1.3

3.2

3.7

u/ml

0.15

611

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

524

4295

1.22

4.71

7.9

4.9

24.4

24.5

mmol/l

0.68

498

4070

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

128

850

1.51

4.70

1.4

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

463

3747

1.24

4.69

4.8

3.8

0.7

0.35

445

3596

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

439

3534

1.25

4.67

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1154

10126

1.15

4.66

2.1

1.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

558

4609

1.22

4.65

3.0

2.5

0.2

0.3

e6/l

0.30

541

4457

(3006653) Thiamine [Moles/volume] in Blood

484

1.67

4.65

1.3

134.4

135.9

nmol/l

0.11

484

(4094501)

306

2361

1.30

4.62

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

131

878

1.49

4.61

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

131

879

1.49

4.59

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

551

4554

1.21

4.57

1.6

3.9

3.6

mg/l

0.19

399

3109

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

131

880

1.49

4.56

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

274

1.89

4.55

1.1

—

(3003181) Sodium [Moles/volume] in Urine

190

1369

1.39

4.54

2.2

1.6

68.2

64.6

mmol/l

0.54

157

1096

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

122

2.37

4.50

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

275

2099

1.31

4.50

2.8

3.1

1.1

2.4

ratio

1.48

195

(3034860) Kappa light chains.free [Mass/volume] in Serum

282

2162

1.31

4.47

2.9

3.1

45.9

78.3

mg/l

0.65

199

1752

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

119

788

1.51

4.45

1.5

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

799

6847

1.17

4.43

1.1

—

(1761868) Lipid panel - Serum or Plasma

4132

38921

1.09

4.38

2.7

2.5

—

(3044941) Cell count panel - Synovial fluid

183

1319

1.39

4.38

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

410

1.70

4.35

1.4

1.5

7.2

4.1

0.30

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.22

4.32

1.4

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

534

4430

1.21

4.28

2.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

144

2.22

4.28

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

280

2159

1.30

4.28

3.0

3.2

43.0

47.2

mg/l

0.12

198

1752

(40760888) Immunoglobulin light chains.free panel - Serum

218

1623

1.34

4.27

2.9

3.2

—

(3024928) Oxygen saturation in Venous blood

247

1873

1.32

4.26

5.2

4.8

—

(40768446) Kidney Pathology biopsy report

429

1.68

4.22

2.2

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.68

4.21

1.0

1.2

1.4

1.6

umol/24h

0.92

(3028707) Methadone [Presence] in Urine by Screen method

378

3033

1.25

4.18

3.2

2.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

326

1.78

4.17

1.4

1.2

24.9

17.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3034

28268

1.09

4.13

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

192

1411

1.36

4.10

1.3

1.2

0.2

nmol/l

0.27

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

151

1066

1.42

4.10

1.6

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

487

1.62

4.07

1.6

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

257

1.86

4.05

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

272

1.83

4.02

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

441

3617

1.22

4.00

1.8

1.5

g/l

0.06

374

3126

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

142

2.18

4.00

1.1

—

(3020891) Body temperature

396

3214

1.23

3.97

5.7

4.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

586

4941

1.19

3.97

1.9

1.8

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.92

3.95

1.3

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

275

1.81

3.89

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

3342

31337

1.08

3.88

2.4

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

276

1.81

3.85

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

433

1.64

3.84

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

218

1652

1.32

3.82

1.5

—

(3042631) Mycobacterium sp identified in Specimen

141

997

1.41

3.82

2.5

2.7

—

(44813793)

133

932

1.43

3.80

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

273

2138

1.28

3.75

1.3

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

378

3077

1.23

3.71

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

250

1939

1.29

3.71

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1092

9699

1.13

3.71

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

438

1.62

3.68

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

416

3424

1.22

3.67

6.1

4.0

49.5

50.0

0.16

406

3380

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

116

798

1.45

3.67

1.5

33.3

34.0

0.07

482

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

501

1.57

3.66

2.1

2.4

26.3

119.6

ug/l

0.92

474

(3003338) MCHC [Mass/volume]

9669

94428

1.08

3.60

18.3

14.9

333.2

333.0

g/l

1.52

9612

93729

(3023183) Ammonium ion [Moles/volume] in Plasma

245

1905

1.29

3.58

3.6

2.9

35.5

34.6

umol/l

0.24

218

1646

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

302

2409

1.25

3.58

1.4

1.3

—

(3049717) Cytology report of Urine Cyto stain

319

2561

1.25

3.57

2.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

435

1.61

3.54

1.4

1.7

3.8

5.8

mmol/24h

—

(3008898) HLA-B27 [Presence]

532

4498

1.19

3.53

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

514

1.55

3.52

3.8

2.4

240.2

171.4

umol/l

0.63

256

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

375

1.65

3.50

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

151

1101

1.37

3.46

6.8

7.0

11.1

mg/l

0.01

138

1028

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

311

2505

1.24

3.40

1.7

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

568

4848

1.17

3.39

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

349

2848

1.23

3.38

1.1

3.5

6.3

u/ml

4.35

191

1618

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

279

2222

1.26

3.38

1.3

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.65

3.36

1.1

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

198

1511

1.31

3.36

1.7

653.3

2086.7

titre

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

253

1.77

3.31

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

253

1.77

3.31

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

253

1.77

3.31

1.1

—

(3032641) Amino acids panel - Urine

3.43

3.31

1.1

1.2

—

(4306422)

228

1777

1.28

3.30

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

106

734

1.44

3.28

4.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

357

2932

1.22

3.27

2.0

1.9

3.8

2.1

ug/l

0.87

310

2612

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

8.54

3.25

4.3

8.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1640

15012

1.10

3.25

1.9

1.7

1.4

0.10

1454

13425

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2454

22877

1.08

3.23

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

334

2731

1.22

3.20

1.1

0.7

1.3

u/ml

1.64

151

1328

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

327

2668

1.23

3.20

1.7

1.4

279.3

253.3

u/ml

0.59

198

1646

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

168

1263

1.33

3.19

1.3

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

217

1691

1.28

3.17

1.1

117.1

116.9

0.05

185

1540

(3011288) Drugs identified in Urine by Screen method

562

4822

1.17

3.16

3.0

2.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

225

1763

1.28

3.15

1.2

1.3

3.0

4.2

u/ml

2.25

105

787

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.72

3.12

2.1

1.5

20.1

24.3

nmol/l

0.14

(3028679) Herpes simplex virus Ab [Presence] in Serum

100

693

1.44

3.11

1.3

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

124

2.09

3.10

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

362

2996

1.21

3.08

1.2

1.3

81.4

132.3

titre

1.36

287

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

843

9431

0.88

3.08

1.5

—

(3021788) Differential panel - Synovial fluid

203

1575

1.29

3.08

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

491

4181

1.18

3.05

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

180

1.88

3.05

2.5

2.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

469

1.53

3.03

1.2

—

(3002256) Pathology report gross observation

1367

12447

1.11

3.02

1.3

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

375

1.60

3.02

1.7

1.5

14.0

14.4

pmol/l

0.33

315

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

271

2182

1.24

3.02

1.4

25.3

24.6

u/l

0.11

219

1815

(3034770) Mitochondria Ab [Titer] in Serum

355

2943

1.21

2.99

1.2

1.3

709.1

977.7

titre

0.46

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

109

774

1.41

2.98

12.0

11.9

0.7

0.6

mmol/l

1.29

100

714

(3045683) HLA typing for celiac disease panel - Blood or Tissue

111

791

1.40

2.97

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

501

4283

1.17

2.97

11.2

10.2

24.2

mmol/l

0.09

468

4028

(21494814) CD8 cells/100 lymphocytes in Specimen

393

1.57

2.95

2.2

2.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

480

4094

1.17

2.93

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

2.14

2.93

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

129

946

1.36

2.92

1.7

1.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

183

1.85

2.91

1.1

1.0

0.2

0.1

u/ml

0.09

112

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

226

1791

1.26

2.91

1.1

—

(3042733) HLA Ab [Presence] in Serum

379

1.58

2.91

5.0

4.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

155

1.93

2.90

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

3.32

2.88

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

306

2512

1.22

2.86

3.9

4.6

0.3

u/ml

0.05

179

1406

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

291

2379

1.22

2.84

1.4

1.3

3.9

4.0

ug/l

0.12

268

2185

(40761539) Cells [Type] in Urine sediment by Light microscopy

236

1.73

2.83

1.4

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

134

995

1.35

2.81

1.1

1.2

1.9

3.1

u/ml

0.51

394

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

339

2818

1.20

2.80

1.6

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

379

3183

1.19

2.80

1.2

1.1

1.0

2.1

u/ml

3.00

158

1435

(3008037) Lactate [Moles/volume] in Venous blood

200

1571

1.27

2.79

3.8

3.0

1.4

1.6

mmol/l

0.82

190

1528

(3027923) C peptide [Moles/volume] in Serum or Plasma

479

1.50

2.78

1.7

1.8

1.2

1.3

nmol/l

0.35

370

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.43

2.78

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1380

12629

1.10

2.77

2.3

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

457

1.51

2.73

1.2

1.1

—

(3036603) Volume of Urine

579

1.45

2.73

1.7

1.6

1796.6

1982.9

0.41

116

(3037756) Immunofixation for Serum or Plasma

180

1400

1.28

2.72

1.4

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

770

6834

1.13

2.72

1.3

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

285

1.65

2.70

1.2

91.5

82.5

0.35

(3016228) CD19 cells/100 cells in Blood

404

1.53

2.65

2.2

2.1

8.5

8.8

0.09

392

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1333

12206

1.10

2.65

2.8

0.7

ug/l

0.21

827

7503

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

252

2047

1.23

2.64

1.1

9.0

11.3

au/ml

0.26

120

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

168

1.84

2.63

1.1

0.0

0.2

u/ml

0.54

103

(3025468) Yersinia sp identified in Specimen by Organism specific culture

157

1206

1.30

2.62

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

227

1826

1.24

2.61

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

177

1384

1.28

2.59

1.3

—

(3028433) Virus identified in Specimen by Culture

359

1.56

2.59

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

538

1.45

2.55

1.0

96.3

93.6

0.37

435

(3019230) Fractional oxyhemoglobin in Venous blood

201

1601

1.25

2.53

5.5

4.9

64.8

65.4

0.15

201

1596

(3000012) Reticulocyte production index

425

1.50

2.53

1.6

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

108

792

1.36

2.50

1.2

1.4

10.9

11.5

umol/l

0.41

758

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

160

1242

1.29

2.49

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

156

1209

1.29

2.46

1.4

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

328

2755

1.19

2.46

4.1

4.0

1.3

1.4

mmol/l

0.37

323

2704

(44816559) Phosphatidylethanol [Mass/volume] in Blood

285

2365

1.20

2.44

1.3

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

228

1850

1.23

2.44

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

217

1.70

2.44

1.3

44.9

39.0

0.49

146

(3005988) Vibrio sp identified in Specimen by Organism specific culture

156

1211

1.29

2.44

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

325

1.57

2.43

2.2

2.8

28.2

28.3

umol/l

0.02

235

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

397

1.51

2.42

1.3

1.2

108.0

108.8

0.07

355

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

187

1486

1.26

2.42

2.6

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

2.54

2.42

3.0

2.3

31.1

40.6

umol/l

1.96

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

130

1.92

2.42

1.8

1.9

—

(3011897) Casein IgE Ab [Units/volume] in Serum

350

1.54

2.40

1.2

1.4

2.4

9.1

u/ml

1.47

(3017704) Immunofixation for Urine

366

1.53

2.40

1.2

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.93

2.39

4.1

3.5

—

(4268621)

159

1241

1.28

2.39

2.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

723

0.65

2.37

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

132

1007

1.31

2.36

3.2

11.2

7.2

7.4

mmol/l

0.21

110

828

(3042111) Morphology [Interpretation] in Bone marrow Narrative

161

1261

1.28

2.36

1.6

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

305

1.57

2.33

2.3

2.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

190

1.73

2.33

2.2

2.8

49.0

30.4

mg/l

0.34

(3010503) CD19 cells [#/volume] in Blood

607

1.40

2.33

2.8

2.7

0.2

0.3

e9/l

0.88

589

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

234

1915

1.22

2.33

1.1

2.9

3.5

u/ml

0.18

100

938

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

442

1.47

2.32

1.9

2.4

10.2

9.4

mg/l

0.57

363

(3004809) Band form neutrophils/100 leukocytes in Blood

179

1424

1.26

2.31

3.6

3.4

1.2

1.4

0.66

136

1108

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

435

1.47

2.29

1.3

1.2

0.3

g/l

0.55

352

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

363

1.51

2.27

3.0

2.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.37

2.27

1.1

1.7

42.1

42.5

umol/l

0.01

(3051593) INR in Capillary blood by Coagulation assay

292

1.57

2.26

8.9

9.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

219

1788

1.22

2.24

1.0

1.1

0.7

0.5

u/ml

0.17

446

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.06

2.24

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

612

1.39

2.23

1.8

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

413

1.47

2.23

1.8

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

247

2043

1.21

2.22

1.1

7.9

6.8

u/ml

0.15

102

918

(3004446) Plasmodium sp identified in Blood by Light microscopy

127

1.88

2.22

2.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

265

2207

1.20

2.22

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

106

792

1.34

2.21

1.3

132.8

97.4

pmol/l

0.23

238

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

149

1.81

2.21

1.5

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

154

1212

1.27

2.19

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2023

19000

1.07

2.18

2.3

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

128

1.87

2.18

1.9

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

400

1.47

2.16

1.1

114.1

149.3

ng/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

115

874

1.31

2.15

1.1

0.2

1.2

u/ml

1.20

168

(3014599) Egg white IgE Ab [Units/volume] in Serum

126

970

1.30

2.14

1.1

4.5

8.7

u/ml

0.43

340

(3001964) Herpes simplex virus Ag [Presence] in Specimen

336

1.51

2.14

1.6

1.5

—

(3018291) Platelet Ab [Presence] in Serum

4.27

2.14

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

409

1.46

2.14

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.99

2.13

1.1

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

154

1218

1.26

2.12

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

619

1.37

2.11

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

535

1.40

2.10

1.5

1.6

1084299.2

1781612.1

iu/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

263

2205

1.19

2.07

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

181

1463

1.24

2.07

4.0

3.1

7.5

7.4

mmol/l

0.13

173

1428

(3012989) Citrate [Moles/time] in 24 hour Urine

3.49

2.04

1.9

1.5

2.2

2.0

mmol/24h

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

146

1.78

2.03

1.6

1.3

20.9

15.6

nmol/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

593

5286

1.12

2.03

1.6

1.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.99

2.03

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

133

1040

1.28

2.02

2.4

2.0

23.1

25.2

mg/l

0.20

283

(3029075) Extractable nuclear Ab panel - Serum

357

1.48

2.02

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

276

2330

1.18

2.02

4.1

4.2

3.9

mmol/l

0.03

265

2187

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

463

5220

0.88

2.01

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

285

1.54

2.01

1.2

1.1

90.5

74.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

215

1.62

1.99

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

215

1.62

1.99

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

215

1.62

1.99

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

215

1.62

1.99

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

737

1.33

1.99

1.1

ratio

0.03

248

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2211

20896

1.07

1.98

2.4

2.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

107

816

1.31

1.98

1.2

1.3

0.3

1.2

u/ml

1.50

324

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

722

1.33

1.96

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

112

1.87

1.93

1.0

0.5

1.6

u/ml

0.48

(3004775) Volume in Urine collected for unspecified duration

604

1.35

1.92

2.2

2.3

691.3

635.0

0.52

436

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

444

1.42

1.92

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

411

1.43

1.91

1.3

1.4

—

(3019225) pH of Specimen

915

8374

1.10

1.91

4.1

4.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

614

1.35

1.90

1.1

1656.6

1497.8

miu/ml

0.64

614

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

172

1.68

1.90

1.1

1.2

0.5

77.4

mg/l

1.20

125

(3041354) Potassium [Moles/volume] in Venous blood

111

857

1.29

1.89

2.8

2.2

4.1

4.0

mmol/l

0.52

111

847

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

266

1.54

1.88

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

438

1.41

1.87

1.3

9.1

12.3

u/l

2.52

407

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

356

1.46

1.86

2.7

2.4

168.9

117.4

ng/l

0.38

236

(3033705) Calcium.ionized [Moles/volume] in Venous blood

108

834

1.29

1.84

2.9

2.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

458

4047

1.13

1.84

1.6

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

151

1.72

1.84

1.5

1.9

19.0

40.6

pmol/l

2.43

129

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

260

1.53

1.83

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

188

2253

0.83

1.82

2.1

2.0

—

(21494434) Karyotype in Bone marrow

706

1.31

1.80

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

1240

13225

0.93

1.80

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.03

1.79

1.3

1.4

3.8

3.1

mu/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.56

1.79

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

621

1.33

1.78

5.0

6.7

—

(3035285) Chloride [Moles/volume] in Venous blood

110

856

1.28

1.78

2.8

2.2

106.1

105.5

mmol/l

0.70

110

846

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

123

1.78

1.77

1.4

69.7

57.8

—

(4035726)

860

7885

1.09

1.74

1.5

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

420

1.40

1.73

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

272

1.50

1.72

1.3

1.6

9.4

8.7

ug/l

0.51

272

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

454

1.38

1.72

1.1

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

193

1.60

1.71

1.0

1.1

0.0

1.3

u/ml

1.47

106

(3000475) Leukocytes [#/volume] in Synovial fluid

241

2047

1.18

1.70

1.7

1.6

8332.3

13448.6

e6/l

1.48

174

1480

(3014133) Dog dander IgE Ab [Units/volume] in Serum

260

2223

1.17

1.69

1.1

8.0

5.0

u/ml

0.39

105

948

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

103

1.84

1.69

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

627

1.32

1.69

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

435

4859

0.89

1.68

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

611

1.32

1.67

1.4

1.5

5.2

6.2

u/l

1.44

525

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

435

4855

0.89

1.66

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

629

1.32

1.66

1.3

6.4

6.2

mmol/l

0.16

581

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

195

1.58

1.65

1.0

1.1

0.1

2.7

u/ml

0.77

103

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

172

1.62

1.64

1.0

1.1

0.4

u/ml

0.35

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.79

1.64

1.0

1.4

—

(3036180) Methadone [Presence] in Urine

2.79

1.64

6.3

2.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

350

1.42

1.63

4.2

4.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.97

1.62

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

389

3438

1.13

1.60

1.9

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

118

941

1.25

1.60

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

120

1.74

1.59

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

434

4829

0.89

1.59

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

379

4251

0.88

1.59

1.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

150

1229

1.22

1.59

1.1

97.1

94.9

0.49

132

1160

(40763791) Oxygen content in Venous blood by calculation

2.49

1.58

5.4

8.6

11.8

12.1

ml/dl

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

325

2843

1.14

1.57

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

136

1.69

1.56

3.7

3.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.10

1.53

4.5

5.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

437

4845

0.89

1.51

1.4

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.58

1.50

1.0

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

153

1.63

1.50

1.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

745

1.27

1.50

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

745

1.27

1.50

1.5

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

745

1.27

1.50

1.5

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

290

1.44

1.49

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.15

1.49

2.0

1.6

—

(3045716) Anion gap in Serum or Plasma

357

1.40

1.48

3.0

2.2

9.3

9.4

mmol/l

0.14

270

(3016750) Collection duration of Urine

459

1.35

1.48

2.1

2.2

508.5

499.0

min

0.27

360

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

323

3639

0.88

1.47

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

229

1964

1.16

1.47

2.1

2.3

0.9

0.8

nmol/l

1.02

194

1659

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

783

1.26

1.46

2.4

2.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

695

1.28

1.46

1.4

58.8

68.7

umol/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

108

864

1.25

1.45

1.2

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.21

1.45

1.3

1.4

6.0

0.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

191

1618

1.18

1.44

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

109

874

1.24

1.44

1.1

7.9

iu/ml

0.01

201

(1001926) Buprenorphine [Presence] in Urine by Screen method

604

5507

1.10

1.44

2.6

2.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

505

1.32

1.43

5.7

6.2

40.3

6627.7

u/ml

0.57

106

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

156

1.60

1.41

2.0

2.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

354

3951

0.89

1.40

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2495

23898

1.05

1.40

2.4

2.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

438

1.34

1.40

1.7

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

438

1.34

1.40

1.7

2.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

118

1434

0.82

1.39

1.7

1.6

7.5

7.6

mmol/l

0.11

861

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

878

0.77

1.36

1.9

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

144

1197

1.20

1.36

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

407

1.35

1.34

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

433

1.34

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

258

2252

1.14

1.34

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

442

1.33

4.2

6.1

69.8

899.8

mg/l

0.78

333

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.75

1.33

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.14

1.33

1.2

2.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

416

0.67

1.32

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

555

5064

1.10

1.32

1.3

252.7

228.0

miu/ml

0.83

252

2482

(3002621) Streptococcal DNAse B [Units/volume] in Serum

159

1.57

1.32

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

531

1.30

1.3

1.5

26.0

19.8

u/ml

—

111

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

160

1.56

1.29

1.4

1.6

62.8

58.4

ng/l

0.06

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

217

1.47

1.28

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

545

4979

1.09

1.27

1.5

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.75

1.27

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

267

1.42

1.27

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

507

1.30

1.26

1.2

—

(3017509) Phencyclidine [Presence] in Urine

177

1.52

1.26

2.0

1.8

—

(3011648) Oxygen content in Venous blood

801

1.23

1.24

7.2

5.9

11.3

0.05

801

(3008116) Ketones [Moles/volume] in Urine by Test strip

194

1.49

1.24

2.0

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

563

1.28

1.22

1.4

1.3

295.6

386.6

u/l

1.31

540

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

732

1.24

1.21

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.62

1.21

1.2

1.1

92.0

90.7

nmol/24h

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

349

3857

0.90

1.20

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

485

1.30

1.20

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

725

1.24

1.19

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

109

1308

0.83

1.18

1.6

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.82

1.18

1.2

1.5

390.0

310.8

umol/24h

0.34

(44806071)

170

0.53

1.17

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

149

1.54

1.15

4.4

5.3

54.3

40.5

ug/min

0.46

102

(3010726) Horse dander IgE Ab [Units/volume] in Serum

307

2742

1.12

1.15

1.1

2.8

2.6

u/ml

0.09

758

(3006922) Hepatitis E virus Ab [Presence] in Serum

792

1.22

1.14

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

102

1.66

1.14

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

190

1.47

1.14

3.4

2.4

—

(3005033) Fetal Nuchal fold Thickness US

350

3847

0.90

1.11

1.4

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

183

1.47

1.11

2.0

1.8

—

(3025130) Human papilloma virus identified in Specimen

206

1801

1.14

1.10

1.7

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

119

1.59

1.09

1.3

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

267

1.38

1.09

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

143

1.53

1.09

1.3

1.1

5.8

4.8

pmol/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

475

1.28

1.09

1.0

745.1

751.2

ng/l

0.04

330

(3010144) Erythrocytes [#/volume] in Synovial fluid

788

1.22

1.09

1.3

1.4

55565.0

95852.2

e6/l

0.63

547

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

406

1.30

1.07

1.1

—

(3025315) Body weight

1.81

1.07

2.3

3.4

—

(3017732) Neutrophils [#/volume] in Blood

779

7282

1.07

2.4

2.6

4.1

e9/l

0.37

629

5918

(3034426) Prothrombin time (PT)

407

1.30

1.06

1.1

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

122

1028

1.18

1.05

1.1

—

(4211845)

532

0.75

1.05

3.1

2.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

478

1.27

1.05

1.0

44.3

43.2

ng/l

0.07

340

(3051101) Glucose [Moles/volume] in Cord blood

123

0.49

1.04

2.7

6.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

262

1.37

1.03

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

126

1068

1.18

1.02

3.9

4.5

110.0

92.4

u/ml

0.16

324

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

114

959

1.19

1.01

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.83

1.01

1.4

1.5

2.4

31.3

—

(3045142) Bone marrow Pathology biopsy report

111

932

1.19

1.01

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

323

1.33

1.01

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

130

1.53

1.00

1.2

1.9

1.8

mmol/l

0.16

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

412

3767

1.09

1.00

2.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

473

1.26

0.99

1.0

344.2

322.6

ng/l

0.19

341

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

205

1.41

0.98

1.1

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

404

1.28

0.97

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

404

1.28

0.97

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

468

0.74

0.97

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

181

2046

0.88

0.97

3.4

3.2

24.9

26.2

mg/l

0.23

115

1247

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.94

0.96

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

340

0.70

0.95

3.1

3.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

887

0.82

0.95

1.3

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

450

1.26

0.95

1.5

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

450

1.26

0.95

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

450

1.26

0.95

1.5

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

190

1.42

0.94

1.5

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

157

1.46

0.94

1.4

1.7

74.8

119.5

ng/l

2.03

157

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

339

0.70

0.94

6.2

6.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

748

1.20

0.93

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.88

0.93

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

451

1.26

0.93

1.5

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.21

0.93

2.0

5.2

—

(3024869) Neuronal Ab [Presence] in Serum

141

1.48

0.93

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

215

1911

1.12

0.92

4.9

3.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

191

1.41

0.92

1.9

2.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

242

1.36

0.92

1.2

1.1

9.1

3.1

u/ml

0.73

201

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

479

1.25

0.91

1.0

6.0

10.5

u/ml

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.72

0.91

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.81

0.91

2.1

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.81

0.91

1.6

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

166

1455

1.14

0.90

1.2

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

235

1.36

0.89

1.3

1.8

30.2

36.7

u/l

0.16

217

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

110

1.54

0.89

1.1

5.1

23.6

u/ml

2.66

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.74

0.89

1.3

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

244

1.35

0.88

1.2

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.90

0.88

2.9

4.9

—

(3006462) Nitrate [Presence] in Urine

493

0.77

0.88

3.2

2.8

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

236

1.35

0.87

1.1

1.3

8.2

u/ml

2.24

199

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.78

0.86

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

601

1.21

0.85

1.6

1.5

5.5

4.9

u/l

0.13

289

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

475

1.24

0.85

1.1

80.3

85.4

u/l

0.17

375

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.71

0.85

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

259

2341

1.10

0.84

2.7

2.4

7.4

6.7

umol/l

0.26

197

1742

(3018738) Hemoglobin F/Hemoglobin.total in Blood

153

1.43

0.84

3.9

3.5

5.2

6.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

104

1.53

0.83

1.2

3.7

2.1

mmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.56

0.83

1.6

1.5

—

(3033799) Differential panel - Peritoneal fluid

237

0.67

0.82

3.1

2.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.75

0.82

1.7

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

205

1834

1.12

0.82

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

426

1.24

0.79

2.4

176.7

149.8

nmol/l

0.91

369

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.81

0.78

1.2

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.72

0.78

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

745

1.18

0.78

1.4

1.2

17.3

42.8

u/ml

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.78

0.0

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

727

1.18

0.78

1.3

1.2

95.0

62.7

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

472

1.23

0.78

1.1

1.2

17.8

22.6

u/l

0.43

360

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

114

1.49

0.78

1.1

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

545

1.21

0.77

1.4

—

(44806420)

156

1.41

0.77

2.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

473

1.22

0.77

3.4

2.6

61.6

49.8

umol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

216

1.34

0.76

5.8

6.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

244

0.69

0.76

3.4

2.0

71195.2

15676.5

e6/l

0.59

131

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

115

998

1.15

0.76

1.2

101.2

68.7

u/l

0.35

676

(3012898) Urea [Moles/volume] in Urine

107

1.49

0.74

1.3

1.7

170.1

164.0

mmol/l

0.06

100

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.08

0.74

1.0

1.4

118.2

75.0

e6/l

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.66

0.74

1.3

1.8

170.1

187.5

ng/l

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

149

1.40

0.74

9.3

13.9

0.5

0.4

umol/l

0.27

140

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.53

0.74

1.4

1.3

204.0

429.6

u/l

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

732

1.17

0.73

1.3

1.2

49.8

41.0

u/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

158

1.39

0.72

1.1

—

(3012441) Differential panel - Pleural fluid

660

1.18

0.72

1.4

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

150

1.40

0.71

1.2

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

150

1.40

0.71

1.0

1.1

0.6

1.3

u/ml

0.83

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

600

5655

1.06

0.71

2.9

3.1

86.7

44.4

u/ml

0.40

583

5467

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

878

0.85

0.71

1.0

1.1

281.3

288.8

mg/l

0.40

797

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.70

0.69

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

353

1.24

0.69

1.7

2.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.55

0.69

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.84

0.68

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

345

1.24

0.68

1.7

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

345

1.24

0.68

1.7

2.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

701

1.17

0.68

1.3

1.2

2.3

12.4

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

109

952

1.14

0.68

1.7

1.5

1.4

1.3

promille

0.02

707

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

536

1.19

0.67

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

454

1.21

0.67

1.2

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

204

1.32

0.67

3.5

4.5

41.7

73.3

u/l

0.69

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

702

1.16

0.67

2.0

1.9

—

(3030313) Adrenal Ab [Titer] in Serum

144

1.38

0.66

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.78

0.66

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

170

1.35

0.66

1.8

1.9

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.48

0.65

1.8

1.4

1.7

1.5

ml/s/173m2

—

(3006270) Folate [Moles/volume] in Blood

741

1.16

0.65

1.1

366.7

389.5

nmol/l

0.50

663

(4281824)

1030

0.87

0.65

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

492

0.81

0.65

2.7

3.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.58

0.64

1.3

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

156

1399

1.11

0.64

2.7

3.1

112.2

965.9

u/ml

0.64

151

1297

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

165

0.66

0.63

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

601

6295

0.95

0.63

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

322

1.24

0.63

2.8

2.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

207

1.30

0.62

1.7

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

104

1.44

0.61

10.7

10.5

8.0

5.6

mmol/l

0.68

104

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.66

0.61

5.6

8.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.61

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

311

0.77

0.60

1.8

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

191

1.30

0.59

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.59

0.0

1.1

—

3.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

842

1.14

0.59

1.5

1.4

33.1

34.0

g/l

0.32

764

(3016879) Cocaine [Presence] in Urine

688

6554

1.05

0.58

2.5

2.0

—

(40757373) Influenza virus identified in Isolate

174

1.32

0.58

1.8

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

236

1.27

0.58

6.2

6.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

527

1.17

0.58

3.0

3.2

136.3

134.4

au/ml

0.01

(3000764) Benzodiazepines [Presence] in Urine

741

7074

1.05

0.58

2.4

2.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

105

928

1.13

0.58

1.2

1.3

102.9

200.7

titre

2.62

175

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

418

0.81

0.57

2.1

2.0

18.5

146.7

ug/min

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

817

1.13

0.56

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.57

0.56

1.0

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1512

15481

0.97

0.55

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.52

0.54

2.8

3.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

124

1.37

0.54

8.2

8.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

147

0.68

0.54

1.9

4.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

550

1.16

0.53

1.1

36.8

21.5

u/ml

0.16

363

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

224

2404

0.93

0.53

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

554

0.84

0.53

2.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.45

0.52

1.3

1.2

1.7

1.6

mg/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.45

0.52

1.1

—

(3045424) Erythrocytes [Presence] in Urine

184

1687

1.09

0.52

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.42

0.52

1.2

1.1

3.9

9.5

mg/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

937

1.12

0.51

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

322

1.21

0.51

3.3

3.2

—

(3028300) Cannabinoids [Presence] in Urine

744

7132

1.04

0.50

2.5

2.0

—

(3044007) Cell count panel - Peritoneal fluid

224

0.76

0.50

1.9

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

431

4517

0.95

0.50

1.5

1.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.46

0.49

2.5

5.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

592

1.14

0.49

1.1

1.2

1.6

13.7

u/ml

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

518

1.15

0.49

1.1

229.5

188.0

iu/ml

0.30

513

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.55

0.48

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

136

1.32

0.48

7.6

7.4

—

(40768793) Breast Pathology biopsy report

241

2247

1.07

0.47

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

102

1.37

0.46

1.1

—

(3003694) ABO and Rh group [Type] in Blood

3255

32909

0.98

0.45

1.5

1.6

—

(3001556) Androgen free Index in Serum or Plasma

182

1.26

0.45

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

740

7118

1.04

0.44

2.4

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

210

1.23

0.43

1.1

—

(3024932) HLA-DR beta [Type]

394

1.16

0.43

1.1

—

(3022621) pH of Urine by Test strip

653

6272

1.04

0.43

3.0

2.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.61

0.43

1.0

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

184

0.76

0.42

1.1

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

101

913

1.10

0.42

1.5

1.4

30.3

31.7

nmol/l

0.20

838

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.56

0.42

1.4

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

451

1.15

0.42

1.3

50.0

65.0

titre

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

573

1.13

0.41

3.5

3.9

9.0

8.1

mg/l

0.61

465

(3035880) pH of Pleural fluid

349

1.17

0.41

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

176

1.25

0.40

1.2

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

1.47

0.40

1.0

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.33

0.40

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1772

17305

1.02

0.40

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

104

0.67

0.39

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

614

1.12

0.39

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

861

1.10

0.39

3.5

3.4

59.7

56.0

0.98

552

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

557

0.88

0.38

1.3

—

(3044927) Protein electrophoresis panel - Urine

681

1.11

0.38

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.40

0.38

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

223

1.21

0.38

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

223

1.21

0.38

1.2

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.38

0.38

1.0

1.2

201.2

307.0

nmol/l

—

(3019977) pH of Arterial blood

437

1.14

0.37

3.6

2.9

7.4

0.16

142

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

142

1.26

0.37

1.1

1.0

3.1

2.7

u/ml

0.05

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

112

0.71

0.37

4.6

3.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

157

0.76

0.36

1.6

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

116

1.29

0.36

2.1

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

533

1.12

0.36

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

195

1829

1.06

0.35

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

211

0.80

0.35

1.8

1.9

1.5

3.6

ug/l

—

119

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

149

1589

0.93

0.35

2.9

3.5

259.5

481.8

u/ml

0.49

135

1453

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

240

2268

1.06

0.34

1.7

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

232

0.82

0.34

1.4

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

469

1.13

0.34

1.2

1.3

868.3

435.2

titre

—

(40768800) Prostate Pathology biopsy report

111

1195

0.92

0.34

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.36

0.34

6.3

4.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

274

0.84

0.33

3.3

2.3

16926.1

3637.1

e6/l

0.35

190

(3035320) C reactive protein [Mass/volume] in Body fluid

765

1.09

0.33

2.9

2.3

—

(4038314)

1.31

0.33

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.30

0.33

1.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

211

2218

0.95

0.33

1.2

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

424

1.13

0.32

2.1

2.0

2.5

3.6

ug/l

0.90

370

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

173

1.21

0.31

1.3

—

(4015189)

186

0.80

0.31

1.4

2.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

164

0.79

0.31

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

110

1018

1.08

0.31

1.1

—

(40758292) HTLV I+II Ab panel - Serum

192

1.19

0.31

1.2

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1054

0.93

0.30

1.5

1.4

—

titre

—

(3024471) HLA-A [Type]

398

1.13

0.30

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.29

0.30

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.29

0.30

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

102

943

1.08

0.30

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

371

1.13

0.29

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.25

0.29

2.3

1.8

—

(4034850)

322

3086

1.04

0.28

7.9

8.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

719

0.91

0.28

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

687

1.09

0.28

1.4

40943.3

58602.0

e6/l

0.34

395

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

130

1.23

0.28

1.1

2.6

10.1

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.23

0.27

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

138

0.79

0.26

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

252

1.15

0.26

2.0

2.4

1.7

mmol/l

0.02

188

(3001729) Color of Synovial fluid

0.68

0.26

1.2

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

0.67

0.26

1.4

2.5

104.0

465.7

umol/l

—

(3000330) Specific gravity of Urine by Test strip

420

4315

0.97

0.26

3.9

3.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

104

1.25

0.25

1.5

4.9

10.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

301

2890

1.04

0.25

3.0

3.6

197.7

2133.6

u/ml

1.27

255

2462

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.29

0.25

1.4

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

652

0.92

0.25

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

350

0.88

0.25

2.5

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

817

0.93

0.25

3.0

2.9

24.2

57.4

mg/l

1.71

601

(3025577) Chromium [Mass/volume] in Blood

414

1.11

0.25

2.2

2.1

1.7

2.5

ug/l

1.83

350

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

197

1.16

0.24

1.5

1.6

0.7

0.4

ug/l

0.82

134

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

158

0.82

0.24

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.16

0.24

1.1

1.2

—

(3006598) pH of Arterial cord blood

207

1.16

0.24

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

250

2588

0.96

0.24

1.5

1.4

78.8

118.8

pmol/l

3.01

240

2517

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1312

12866

1.02

0.24

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

954

1.07

0.24

1.7

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

703

1.08

0.24

1.3

—

(3013762) Body weight Measured

1.31

0.23

1.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.31

0.23

13.6

9.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

208

1.15

0.23

1.6

1.2

—

(3045414) Leukocytes [Presence] in Urine

441

4513

0.97

0.22

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.22

1.2

1.1

—

(3024263) Appearance of Synovial fluid

466

1.09

0.21

1.6

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

108

1017

1.06

0.21

4.2

3.7

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3020491) Glucose [Moles/volume] in Blood

775

1.07

0.21

2.1

1.9

7.0

6.2

mmol/l

1.31

586

(40768441) Liver Pathology biopsy report

767

1.07

0.20

1.4

1.5

—

(4133840)

302

0.89

0.20

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

126

1.19

0.20

1.7

1.6

—

(3027944) Amphetamines [Presence] in Urine

718

7020

1.02

0.19

2.4

1.9

—

(3044009) aPTT.lupus sensitive (LA screen)

108

1.20

0.19

1.1

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.17

0.19

1.2

1.1

8.5

8.3

mmol/l

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.15

0.19

3.3

1.6

18.2

17.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

165

1.15

0.18

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

423

1.08

0.18

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

423

1.08

0.18

1.4

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.18

0.18

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

289

1.10

0.18

1.6

1.7

—

(3017569) Oxygen content in Arterial blood

347

1.09

0.17

2.5

2.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

173

0.86

0.17

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1137

11471

0.99

0.17

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

105

1096

0.95

0.17

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

233

1.11

0.16

1.0

1.2

36.6

39.4

g/l

0.28

127

(3022670) pH of Venous cord blood

1.14

0.16

1.0

—

(4212803)

1.14

0.16

1.3

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

167

1.13

0.16

1.3

1.2

8.6

366.4

ug/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

776

1.05

0.15

1.5

1.4

3358.6

2382.3

e6/l

0.20

562

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

398

1.08

0.15

1.1

1.2

42.0

8.3

u/ml

0.67

303

(3015183) Erythrocyte sedimentation rate

654

0.94

0.15

1.2

—

(4024509)

878

0.95

0.15

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

170

1749

0.97

0.15

1.4

6.6

6.9

mmol/l

1.11

128

1262

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.08

0.14

3.0

2.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

169

1.12

0.14

2.1

2.2

7.2

7.3

mmol/l

0.04

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

625

1.05

0.13

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

713

7011

1.01

0.12

1.7

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

158

0.88

0.12

1.8

6.6

—

(40762814) Titanium [Mass/volume] in Blood

113

1.15

0.12

2.5

2.3

2.7

4.3

ug/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

821

8085

1.01

0.12

3.7

4.1

23.7

26.8

ug/l

0.09

603

6338

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

559

1.05

0.12

1.3

1.2

15.0

20.1

u/l

0.91

477

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

576

0.95

0.11

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

197

1916

1.02

0.11

2.6

2.4

127.4

112.7

ug/min

0.18

107

1210

(3038177) Helicobacter pylori Ab [Presence] in Serum

193

1967

0.98

0.10

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

581

1.05

0.10

1.3

1.2

88.5

83.4

u/l

0.08

510

(3041806) Other cells [#/volume] in Blood by Manual count

857

0.96

0.10

1.6

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

258

0.93

0.10

1.3

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

114

0.87

0.10

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

906

1.03

0.10

1.5

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.09

1.0

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.11

0.09

1.0

1.3

180.0

564.4

nmol/l

—

(4198724)

785

0.96

0.09

2.6

2.5

—

(40768806) Pleura Pathology biopsy report

681

1.04

0.09

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

163

1588

1.02

0.09

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

136

1322

1.02

0.09

1.3

55.1

33.0

u/l

0.45

120

1154

(3019174) dRVVT (LA screen)

113

0.88

0.09

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

378

0.95

0.08

2.5

2.2

—

(3000285) Sodium [Moles/volume] in Blood

1.13

0.08

1.5

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

664

1.04

0.08

2.7

1.9

1.6

1.8

u/field

0.12

306

(3022475) Manganese [Moles/volume] in Blood

1.06

0.07

1.4

1.3

—

(3014891) Appearance of Pleural fluid

0.83

0.07

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

150

1522

0.98

0.06

1.6

—

(3003577) Lead [Moles/volume] in Blood

0.87

0.06

1.0

1.3

—

0.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

105

1070

0.98

0.06

3.2

3.1

0.9

0.8

nmol/l

0.54

800

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

118

1.10

0.06

1.0

1.1

—

(3048879) Bone marrow aspiration report

196

1.07

0.06

1.7

2.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

100

0.90

0.06

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

141

0.92

0.06

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.11

0.06

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

810

1.02

0.04

1.3

1.4

nmol/l

0.05

727

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

117

1183

0.99

0.04

1.5

1.4

10.8

11.5

mmol/l

0.33

226

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

791

7845

1.00

0.04

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

380

0.97

0.03

4.0

3.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

178

1790

0.99

0.03

1.1

115.8

5989.8

iu/ml

0.63

453

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

250

1.04

0.02

4.4

3.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

250

1.04

0.02

4.4

3.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

146

1466

0.99

0.02

1.1

1.5

g/l

0.47

129

1337

(4146454)

787

0.99

0.02

3.2

2.7

—

(40765096) Chromosome analysis panel by Banding

251

1.03

0.02

1.2

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

986

9841

1.00

0.02

21.2

19.9

1.3

1.2

inr

0.60

179

1558

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

579

1.02

0.01

1.1

5.3

11.6

u/ml

2.17

109

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

690

1.01

0.01

1.3

1.4

5.5

mmol/l

0.12

653

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

209

1.00

0.00

1.2

1.4

—

(3047189) Immunofixation for 24 hour Urine

312

0.99

0.00

1.7

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

111

0.99

0.00

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

213

0.98

0.00

1.4

1.1

—

(3022689) Creatine [Moles/volume] in Urine

264

1.02

0.00

1.3

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1084

10800

1.00

0.00

4.1

3.9

31.9

32.1

0.25

769

7687

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

495

1.01

0.00

1.6

1.3

2.9

u/field

1.99

360

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

357

1.00

0.00

2.9

2.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

149

1.00

0.00

2.8

678.9

2901.4

u/l

1.18

140

(3020356) Listeria sp identified in Specimen by Organism specific culture

104

0.96

0.00

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.8

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

6.8

—

15.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.4

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.99

0.00

1.0

1.2

—

2.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.95

0.00

1.1

1.3

—

526.2

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

32.8

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.95

0.00

1.0

173.2

164.4

g/l

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.9

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.95

0.00

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.88

0.00

1.0

1.1

8.7

14.1

u/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.95

0.00

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.87

0.00

6.8

4.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_REFRAACCOMMODIS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_REFRAACCOMMODIS	1.15 [1.03, 1.29]	0.016
Birth year	0.996 [0.99, 1.0]	0.323

During the follow-up period (1.1.1998 — 31.12.2019), 2935 out of 56112 females with H7_REFRAACCOMMODIS died.

Males

Parameter	HR [95% CI]	p-value
H7_REFRAACCOMMODIS	1.248 [1.09, 1.43]	0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2510 out of 44720 males with H7_REFRAACCOMMODIS died.

Mortality risk

Mortality risk for people of age

years, who have H7_REFRAACCOMMODIS.

N-year risk	Females	Males
1	0.114%	0.227%
5	0.712%	1.458%
10	1.848%	3.313%
15	3.315%	6.2%
20	5.755%	10.422%

Relationships between endpoints

↥

Index endpoint: H7_REFRAACCOMMODIS – Disorders of refraction and accommodation

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of refraction and accommodation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints